voriconazole has been researched along with Aspergillosis in 782 studies
*Aspergillosis: Infections with fungi of the genus ASPERGILLUS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (1.41) | 18.2507 |
| 2000's | 299 (38.24) | 29.6817 |
| 2010's | 385 (49.23) | 24.3611 |
| 2020's | 87 (11.13) | 2.80 |
| Authors | Studies |
|---|---|
| Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 2 |
| Dierich, MP; Lass-Flörl, C; Lugger, H; Perkhofer, S | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Aguirrebengoa, K; Arteaga, C; Chen, SC; Ellis, D; Heath, CH; Lutsar, I; Nguyen, Q; Rovira, M; Slavin, M; Troke, P | 1 |
| Hashimoto, K; Kaeriyama, M; Kimura, A; Mitsuyama, J; Narita, H; Nishikawa, H; Nomura, N; Todo, Y; Yamada, E | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Bocanegra, R; Fothergill, AW; Graybill, JR; Herrera, ML; Kinney, MC; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Vallor, AC; Wickes, BL | 1 |
| Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M | 1 |
| Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL | 1 |
| Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N | 1 |
| Beernaert, LA; Dorrestein, GM; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L; Vercammen, F; Verstappen, F | 1 |
| Brüggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE | 2 |
| Blisard, D; Capitano, B; Han, K; Husain, S; Johnson, HJ; Kwak, EJ; Linden, PK; Marcos, A; Paterson, DL; Potoski, B; Romkes, M; Venkataramanan, R | 1 |
| Dumoulin, A; Van Hoecke, F; Vangheluwe, T; Vogelaers, D | 1 |
| Beauchemin, C; Claveau, D; Dufresne, SF; Guinan, K; Rotstein, C | 1 |
| Govender, NP; Hoffmann, D; Mitton, B; Rule, R; Said, M | 1 |
| Fukami, T; Kamei, K; Kawashima, M; Matsui, H; Nagai, H; Narumoto, O; Sano, T; Sasaki, Y; Sekiguchi, R; Suzuki, J; Takeda, K; Tamura, A; Watanabe, A; Watanabe, M | 1 |
| Cornely, O; Janssen, S; Mehler, K; Oberthuer, A; Seifert, H; Zweigner, J | 1 |
| Bernards, S; de Boer, MGJ; Hendriks, BJC; Jolink, H; Koopmans, JG; van de Peppel, RJ; van der Beek, MT; van Grootveld, R; van Paassen, J; von dem Borne, PA | 1 |
| Bajel, A; Chen, SC; Douglas, AP; Halliday, CL; Lavee, O; McMullan, B; Smibert, OC; van Hal, SJ; Yong, MK | 1 |
| Guillemain, R; Lillo Le Louet, A; Orssaud, C | 1 |
| Arslan, SY; Bal, ZS; Bilen, NM; Ergun, O; Kurugol, Z; Naghiyev, J; Ozarslan, A; Ozenen, GG; Ozkinay, F; Sakul, G | 1 |
| Aruanno, M; Born, T; Kampouri, E; Lamoth, F; Mombelli, M; Monney, P; Tozzi, P | 1 |
| Aguilar, C; Gohir, W; Henry, B; Husain, S; Klement, W | 1 |
| Butler-Laporte, G; Ferraro, P; Langevin, MC; Lemieux, C; Luong, ML; Poirier, C; Théorêt, Y | 1 |
| Chang, KM; Donaghy, HJ; Jurado, JE; Kim, AC | 1 |
| Azócar, M; Barraza, M; Coria, P; García, P; Miranda, R; Morales, J; Palma, J; Santolaya, ME; Torres, JP | 1 |
| Fisher, BT; Hsu, AJ; Tamma, PD | 1 |
| Bonovas, S; Houhoula, D; Markou, E; Mavrogenis, AF; Papadopoulos, DV; Piovani, D; Sokou, R; Trikoupis, I; Tsakris, A; Tsantes, AE; Tsantes, AG; Vrioni, G; Zarokostas, K | 1 |
| Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y | 1 |
| Babaei, M; Daie Ghazvini, R; Erami, M; Fattahi, M; Getso, MI; Hashemi, SJ; Khodavaisy, S; Mehri, N; Momen-Heravi, M; Parviz, S; Raiesi, O | 1 |
| Duan, Z; Li, M; Liu, Y; Tong, J; Zeng, R; Zheng, N | 1 |
| Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M | 1 |
| Geipel, M; Groll, AH; Heidtmann, S; Kurzai, O; Meier, CM; Müller, R; Papan, C; Praschmo, D; Simon, A; Walther, G; Zemlin, M | 1 |
| Arga, G; Çakmakli, HF; Çiftçi, E; Dinçaslan, H; Doğu, F; Ertem, M; Evren, E; Fitöz, S; Haskoloğlu, Ş; İkincioğullari, A; İleri, T; İnce, E; Karahan, ZC; Kendirli, T; Konca, HK; Kuloğlu, Z; Okulu, E; Özdemir, H; Özen, S; Taçyildiz, N; Taşkin, EÇ; Tutar, E; Ünal, E; Us, E | 1 |
| Azmanis, PN; Binoy, A; Carneiro de Castro, IF; Schmidt, V; Silvanose, CD | 1 |
| Aliakbarian, M; Khaleghi, E; Khodashahi, M; Khodashahi, R; Moghaddam, MD; Naderi, HR; Pasand, MM; Rezayat, KA | 1 |
| Alffenaar, JC; Biemond, BJ; Blijlevens, N; Brüggemann, RJ; de Boer, MGJ; Klein, SK; Kosterink, JGW; Kraemer, D; Minnema, MC; Prakken, NHJ; Rijnders, BJA; Span, LFR; Swen, JJ; van den Heuvel, ER; van der Werf, TS; Veringa, A; Verweij, PE; Wondergem, MJ; Ypma, PF | 1 |
| Bidaud, AL; Botterel, F; Dannaoui, E; Djenontin, E; Guillot, J; Jemel, S; Kallel, A; Kallel, K; Raveloarisaona, Y | 1 |
| Dobashi, A; Imai, M; Imoto, W; Kakeya, H; Kakuno, S; Mitani, K; Niki, M; Ogawa, M; Shibata, W; Takayama, N; Yamada, K | 1 |
| Aguado, JM; Aimanianda, V; Armstrong-James, D; Botterel, F; Chen, YC; Husain, S; Lefort, A; Lortholary, O; Melenotte, C; Saliba, F; Slavin, M; Van Delden, C | 1 |
| Akshatha, R; Balamurugan, T; Bohra, GK; Garg, MK; Jain, V; Kumar, D; Meena, DS; Midha, N; Samantaray, S; Tiwari, S | 1 |
| Gao, L; Sun, Y; Tan, J; Zhang, H | 1 |
| Aram, JA; Engelhardt, M; Hamed, K; Huang, JJ; Kovanda, LL; Yan, J | 1 |
| Gautier-Veyret, E; Stanke-Labesque, F; Thiebaut-Bertrand, A | 1 |
| Alffenaar, JC; Brüggemann, RJ; Veringa, A | 1 |
| Fatahinia, M; Halvaeezadeh, M; Jalaee, GA; Mahmoudabadi, AZ | 1 |
| Huang, Q; Lu, X; Wu, Y; Xia, L | 1 |
| Grandhi, A; Haider, S; Han, S; Klimko, N; Lee, DG; Maertens, JA; Ponce-de-León, A; Rahav, G; Ramirez-Sanchez, IC; Waskin, H; Winchell, GA; Wrishko, R | 1 |
| Bharadwaj, B; Paramasivam, S; Raja, K; Rekha, HS | 1 |
| Bilal, H; Cai, L; Chen, C; Hu, H; Khan, MN; Khan, RU; Khan, S; Shafiq, M; Zeng, Y; Zhang, D | 1 |
| Ao, W; Fu, B; Fu, X; Huang, P; Wang, J | 1 |
| Baharani, A; Reddy P, RR; Reddy, AK | 1 |
| Arbona-Haddad, E; Bold, TD; Chen, K; Cheng, MP; Cummins, KC; Hammond, SP; Koo, S; Kusztos, AE; Liakos, A; Marty, FM; Orejas, JL; Pandit, A; Solomon, IH | 1 |
| Azmanis, P; Naidoo, V; Pappalardo, L; Sara, ZAJ; Silvanose, C | 2 |
| Chatron, E; Hansmann, Y; Karol, A; Martin, A; Petitdemange, A; Ruch, Y | 1 |
| He, J; Huisken, J; Huttenlocher, A; Keller, NP; Rosowski, EE | 1 |
| Caulfield, AJ; Fulton, BK; Olivero, RM | 1 |
| Chen, H; Cheng, L; Li, Y; Liu, F; Sun, F; Xia, P; Xiang, R; Yao, P | 1 |
| Barry-Heffernan, CA; Bray, RN; Leuin, AS; Pritchard, JC; Raghu, CL | 1 |
| Kakizaki, H; Sarbajna, T; Takahashi, Y; Vaidya, A | 1 |
| Becker, T; Both, M; Braun, F; Fickenscher, H; Gundlach, JP; Günther, R; Röcken, C | 1 |
| Dobiáš, R; Hošková, L; Hubka, V; Jaworská, P; Kautznerová, D; Kubánek, M; Lysková, P; Mrázek, J; Němcová, D; Skružná, M; Sumerauerová, P; Vrbská, J; Žáčková, P | 1 |
| Brocal, J; Del Río, FR; Feliu-Pascual, AL | 1 |
| Costa Paiva, SS; Damaceno Costa, L; Marques Fortes, P; Saddi Godinho, TC; Sucasas Costa, P; Viana de Siqueira, AP | 1 |
| Kanai, T; Kashiwa, Y; Kawahara, K; Kim, SH; Matsuoka, H; Morishita, H; Noda, Y; Samejima, Y; Shimizu, K; Tamura, K; Ueda, K; Umakoshi, T; Yaguchi, T | 1 |
| Al Shaarani, M; Joel Chandranesan, AS; Mada, PK; Saldaña Koppel, DA | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA | 1 |
| Barnes, M; Buttar, B; Gondal, K; Kaell, A; Kumar, V; Le, TH; Siddique, H | 1 |
| Furukawa, K; Matsuo, T; Mori, N; Sakurai, A | 1 |
| Dupont, D; Miailhes, P; Mouchel, R; Persat, F; Saison, J; Wallon, M | 1 |
| Farahyar, S; Fattahi, A; Kouhsari, E; Lotfali, E; Saffari, M; Siddig, E; Zaini, F | 1 |
| Ishii, I; Kamei, K; Suzuki, T; Takatsuka, H; Watanabe, A; Yamazaki, S; Yokoyama, I | 1 |
| Capilla, J; Gallego-Arranz, T; Guarnizo-Herrero, V; Pérez-Cantero, A; Torrado-Durán, S; Torrado-Salmerón, C | 1 |
| Cornu, M; Fichet, C; François, N; Le, V; Leroy, J; Loridant, S; Marceau, L; Sendid, B; Vuotto, F | 1 |
| Bannan, A; Grant, P; Lennard, K; Post, J | 1 |
| Beswick, DM; Detwiller, K; Krane, NA; Sauer, D; Shindo, M | 1 |
| Kakkassery, V; Kurzai, O; von Jagow, B | 1 |
| Hu, S; Jin, M; Zhang, S; Zhang, Y; Zhou, G | 1 |
| Chakrabarty, B; Gulati, S; Gupta, J; Jauhari, P; Kumar, A; Singh, G; Singh, S; Xess, I | 1 |
| Agrawal, S; Chaturvedi, J; Dash, C; Goyal, N; Kaistha, N; Meena, S; Narula, H | 1 |
| Hu, YP; Wu, X; Zhang, Y | 1 |
| Chantharit, P; Kasai, H; Tanigawara, Y; Tantasawat, M | 1 |
| Bansal, S; Chatterjee, T; Singhania, N; Yadav, M | 1 |
| Azanza, JR; Grau, S; López-Gómez, V; López-Ibáñez de Aldecoa, A; Peral, C; Rebollo, P; Vázquez, L | 1 |
| Brito Devoto, T; Carmona, M; Cuestas, ML; Formento, N; Gordó, M; Hermida-Alava, K; Luque, A; Sautua, F; Scandiani, M | 1 |
| Abad-Santos, F; Antón, C; Borobia, AM; Bueno, D; Carcas, A; de la Cámara, R; Estébanez, M; Frías Iniesta, J; García García, I; López de la Guía, A; Mejía, G; Monserrat Villatoro, J; Otero, MJ; Ramírez García, E | 1 |
| Bi, W; Cen, H; Huang, K; Li, X; Liu, H; Luo, H; Wang, L; Xue, L; Zeng, Z; Zhang, Y | 1 |
| Asai, K; Imoto, W; Izumi, N; Kakeya, H; Kawaguchi, T; Komatsu, H; Kuwabara, G; Nishiyama, N; Oshima, K; Shibata, W; Sone, R; Watanabe, T; Yamada, K; Yamairi, K | 1 |
| Bertram, S; Deuschl, C; Eckstein, A; Lever, M; Pförtner, R; Rath, PM; Wilde, B; Witzke, O | 1 |
| Abboud, C; Achcar, ME; Bidon, B; Bouchara, JP; Dabboussi, F; Dannaoui, E; Hamze, B; Hamze, M; Mallat, H; Osman, M; Papon, N; Zakaria, A | 1 |
| Denk, D; Guthrie, A; Macgregor, SK; Reed, K; Stidworthy, MF | 1 |
| Abo, YN; Gwee, A; Osowicki, J | 1 |
| Aboutalebian, S; Fakhim, H; Hajiahmadi, S; Hakamifard, A; Hashemi, M; Mohammadi, R | 1 |
| Benoit, P; Ferreira, V; Grandjean Lapierre, S; Halwagi, A; HÉtu, PO; Mathieu, A; Thiboutot, Z | 1 |
| Hsueh, PR; Jing, R; Li, XW; Li, Y; Wang, CY; Xiao, M; Xu, YC; Yang, WH; Zou, GL | 1 |
| Aser, R; Berdat, PA; Flepp, M; Mestres, CA; Mohacsi, P; Schmidlin, D; Vogt, PR; Went, P | 1 |
| Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
| Bohra, GK; Kumar, D; Kumar, G; Meena, DS | 1 |
| Coussement, J; Lindsay, J; Slavin, M; Teh, BW | 1 |
| Bajaj, MS; Kashyap, S; Navarosh, J; Pushker, N; Singh, L; Thakar, A; Xess, I | 1 |
| Chegini, Z; Didehdar, M; Falahati, V; Ghorbani, M; Moradabadi, A; Rajaeih, S; Shariati, A | 1 |
| Guo, Y; Huang, D; Li, X; Liu, L; Liu, Y; Nashan, B; Qin, J; Song, R; Wang, J; Wang, N; Wu, W; Xu, Z; Yao, Z; Zheng, H; Zhu, Z | 1 |
| Crusz, SA; Denning, D; Mitchell, S; Simmonds, L; White, B | 1 |
| Bassetti, M; Bouza, E | 1 |
| Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E | 1 |
| Ivulich, S; Jeong, W; Kong, DCM; Levvey, BJ; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Westall, GP | 1 |
| Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE | 1 |
| D'Inzeo, T; De Carolis, E; Mello, E; Posteraro, B; Sanguinetti, M; Torelli, R; Vella, A; Verweij, PE | 1 |
| Banno, S; Kakizaki, H; Naito, M; Nishimura, K; Ogawa, T; Takahashi, Y; Tanigawa, T; Uchida, Y; Ueda, H; Yamagishi, Y | 1 |
| Brazzarola, P; Cazzadori, A; Colato, C; Concia, E; El Dalati, G; Lanzafame, M; Mangani, F; Nicolè, S; Vincenzi, M | 1 |
| Hayashi, N; Imanishi, T; Kasagi, S; Kurimoto, C; Morinobu, A; Saegusa, J; Yamamoto, T | 1 |
| Ashu, EE; Korfanty, GA; Xu, J | 1 |
| Bennis, Y; Bodeau, S; Chouaki, T; Gourmel, A; Guillaume, N; Lemaire-Hurtel, AS; Lutun, A; Masmoudi, K; Quaranta, S; Solas, C | 1 |
| Hassan, FAM; Tartor, YH | 1 |
| Adams, N; Cormican, S; de Freitas, D; McErlean, A; O'Connell, P | 1 |
| Aquino, VR; Bergamasco, MD; Castro, PTO; Colombo, AL; Gonçalves, SS; Hagen, F; Martino, MDV; Meis, JF; Negri, CE; Queiroz-Telles, F; Sousa, ACP | 1 |
| Anract, P; Archambeau, D; Epelboin, L; Eyrolle, L; Gaume, M; Gauzit, R; Larousserie, F; Lavielle, M; Leclerc, P; Lortholary, O; Marie-Hardy, L; Paugam, A; Roux, C; Salmon, D | 1 |
| Aoki, R; Hiraga, A; Kuwabara, S; Nakamura, K | 1 |
| Chen, P; Guo, W; Long, Y; Luo, M; Peng, H; Song, M; Tan, Y; Zhou, Q | 1 |
| Atay, Y; Ayık, MF; Nart, D; Özdemir Şahan, Y; Şişli, E | 1 |
| Byun, SA; Choi, MJ; Jung, JS; Kim, SH; Park, YJ; Shin, JH; Shin, MG; Suh, SP; Won, EJ | 1 |
| Brüggemann, RJM; Buil, JB; Meis, JF; Melchers, WJG; Mouton, JW; Verweij, PE; Wasmann, RE; Zoll, J | 1 |
| Acharya, NR; Amza, A; Lietman, TM; Loh, A; Mannis, MJ; Oldenburg, CE; Prajna, NV | 1 |
| Haruki, K; Hayashi, A; Hisauchi, I; Kobayashi, S; Komatsu, T; Nakahara, S; Sakai, Y; Taguchi, I | 1 |
| Kim, SH; Kwon, JH; Lee, JS; Yoon, YC | 1 |
| Beekmann, SE; Beer, KD; Chiller, TM; Jackson, BR; Lockhart, SR; Mody, RK; Polgreen, PM; Santibanez, S; Walker, TA | 1 |
| Dürig, J; Gerken, G; Rashidi-Alavijeh, J; Rath, PM; Turki, AT; Witzke, O | 1 |
| Birkenbach, M; Faizer, R; Green, JS; Ustun, C; Wasko, JA | 1 |
| Arwood, MJ; Bulitta, J; Cavallari, LH; Hamadeh, IS; Klinker, KP; Mangal, N; Samant, TS; Schmidt, S | 1 |
| Benedetti, E; Campani, D; Di Candio, G; Di Franco, G; Furbetta, N; Guadagni, S; Morelli, L; Mosca, F; Palmeri, M; Petrini, M; Pieroni, E; Tagliaferri, E | 1 |
| Almaguer, M; Fernández, CM; Illnait, MT; Martínez, GF; Perurena, MR; San Juan, JL; Velar, RE | 1 |
| Bader, O; Becker, K; Groß, U; Idelevich, EA | 1 |
| Avdic, E; Farrokh, S | 1 |
| Deng, Y; Huang, H; Li, S; Peng, L; Wang, B; Yang, R; Yuan, J; Zhang, H; Zhong, J | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Bogoch, II; L'Huillier, AG | 1 |
| Asano, M; Hasegawa, Y; Hashimoto, N; Ishigami, M; Majima, S; Okachi, S; Sato, M; Wakahara, K | 1 |
| Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Mousavi, B; Sharma, C; Vaezi, A | 1 |
| Cho, WH; Kim, D; Kim, HS; Shin, DH; Yeo, HJ | 1 |
| Chappe, M; de Gentile, L; Lagarce, F; Le Govic, Y; Legrand, G; Vrignaud, S | 1 |
| Arendarczyk, A; Hendzel, P; Kurnicka, K; Pruszczyk, P; Zdończyk, O | 1 |
| Bénet, T; Bienvenu, AL; Cassier, P; Dananché, C; Dupont, D; Gustin, MP; Hénaff, L; Loeffert, ST; Vanhems, P; Wallon, M | 1 |
| Choi, EH; Kang, HJ; Lee, HJ; Shin, HY; Sohn, YJ; Yun, JH; Yun, KW | 1 |
| Hayashi, Y; Hoshino, Y; Inukai, T; Kamei, K; Miyazaki, Y; Nagi, M; Nakamura, S; Ogawa, K; Shimosaka, H; Takatsuka, S; Umeyama, T; Yamagoe, S | 1 |
| Abdel Fattah, M; Bigé, N; Danion, F; Guéry, R; Jullien, V; Lanternier, F; Lapusan, S; Lortholary, O; Morgand, M; Pallet, N; Rouzaud, C | 1 |
| Bollmann, T; Ewert, R; Nowak, S; Rathmann, E; Ribback, S; Rosenstengel, C; Schroeder, HWS | 1 |
| Escrig, C; Herbrecht, R; Kuessner, D; Pooley, N; Posthumus, J | 1 |
| Chang, YH; Chang, YM; Chen, YJ; Chien, KH; Liang, CM; Nieh, S; Tai, MC | 1 |
| Abou-Zahr, T; O'Connor, L; Place, E; Reyher, K | 1 |
| Abd Al Aziz, S; Anani, M; Elkholy, A; Hassan, M; Hosny, M; Labib, D; Meshaal, MS; Rizk, H; Said, K | 1 |
| Brugière, C; Comoz, F; Dompmartin, A; Lefranc, H; Plisson, L; Verneuil, L | 1 |
| Folić, M; Janković, SM; Jović, Z; Kostić, M; Milovanović, D; Milovanović, J; Ružić Zečević, D; Stefanović, S | 1 |
| French, B; Mandell, K; Martinez, R | 1 |
| Ali, SA; Khalid, M | 1 |
| Aruanno, M; Bachmann, D; Coste, AT; Delarze, E; Erard, V; Glampedakis, E; Lamoth, F | 1 |
| Andes, DR; Ghannoum, MA; Hope, WW; Jones, ME; Kovanda, LL; Lademacher, C; Lu, Q; Mukherjee, PK; Santerre Henriksen, A | 1 |
| Burkholder, BM; Chang, DS; Crowell, EL | 1 |
| Girmenia, C; Goffredo, BM; Marchesi, F; Mengarelli, A; Menna, P; Minotti, G; Romano, A; Salvatorelli, E | 1 |
| Aït-Ammar, N; Botterel, F; Dannaoui, E; Foulet, F; Imbert, S; Levesque, E; Murat, JB | 1 |
| Chaftari, AM; Dib, RW; Ghaly, F; Hachem, RY; Jiang, Y; Raad, I | 1 |
| Capellier, G; Clairet, AL; Lagoutte-Renosi, J; Millon, L; Navellou, JC; Piton, G; Rougny, AC; Winiszewski, H | 1 |
| Fang, Y; Gong, Y; Hu, Z; Liu, Y; Shen, J; Tan, J; Wu, G; Zhu, H; Zhu, L | 1 |
| Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J | 1 |
| Cattaneo, L; Cereda, AF; Fiocca, L; Iacovoni, A; Senni, M; Sironi, S | 1 |
| Bennis, Y; Chouaki, T; Delette, C; Joseph, C; Maizel, J; Marolleau, JP; Nyga, R; Simon, L; Slama, M; Zogheib, E | 1 |
| Alcazar Fuoli, L; Bernal-Martínez, L; Carvalho, A; Cuétara Garcia, MS; Cunha, C; Garcia-Rodriguez, J; Gómez-García de la Pedrosa, E; Gomez-Lopez, A; Miguel-Revilla, B | 1 |
| Dehghan Manshadi, SA; Giasvand, F; Jahanbin, B; Khodaveisi, S; Safai Nodeh, SR; Salehi, M; Seifi, A | 1 |
| Asahina, A; Itoh, M; Kikuchi, S; Matsuo, H; Mizuno, S | 1 |
| Jun, JB; Jung, J; Lim, DH | 1 |
| Alós-Almiñana, M; Ezquer-Garín, C; Ferriols-Lisart, R; Guglieri-Lopez, B; Hernández-Boluda, JC; Navarro, D; Pérez, A; Perez-Pitarch, A; Piñana, JL; Solano, C | 1 |
| Demura, S; Ebara, H; Hayashi, H; Kagechika, K; Kidani, S; Kitano, Y; Nakamura, Y; Okamoto, S; Shimozaki, K; Takagi, Y; Tsuchiya, H; Ueno, T; Yamada, H | 1 |
| Bearman, G; Beaulieu, C; Fulco, PP; Higginson, RT | 1 |
| Katsube, O; Kono, Y; Soeda, S; To, M; To, Y; Tsuzuki, R; Yamawaki, S | 1 |
| Cornelissen, JJ; De Kort, E; Lagrou, K; Lestrade, PPA; Maertens, J; Mercier, T; Resendiz-Sharpe, A; Rijnders, BJA; Schauwvlieghe, AFAD; van der Beek, MT; Verweij, PE; von dem Borne, PA | 1 |
| Corcoran, TE; Ensor, CR; Hussain, S; Iasella, CJ; McDyer, JF; Moore, CA; Morrell, MR; Nero, JA; Nguyen, MH; Thanukrishnan, H; Venkataramanan, R | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C | 1 |
| Celkan, T; Eroğlu, AG; Ozdemir, N; Tüysüz, G; Uludağ, D | 1 |
| Abdi, R; Basiri, A; Hedayati, MT; Najafi, N; Parvin, M; Shokohi, T; Taghavi, F; Yadegarinia, D | 1 |
| Aram, JA; Barbers, RG; Equils, O; Mardekian, J; McLaughlin, JM; Schlamm, HT; Somerville, KT; Welch, VL | 1 |
| Ahmad, S; Al-Wathiqi, F; Khan, Z | 1 |
| Huitema, AD; Schellens, JH; Schouten-van Meeteren, AY; van Eijkelenburg, NK; van Hasselt, JG | 1 |
| Brock, M; Galiger, C; Ibrahim-Granet, O; Jouvion, G; Parlato, M; Savers, A | 1 |
| Bonhomme, J; de la Blanchardière, A; Hamon, M; Hitier, M; Leclercq, R; Nicolle, A | 1 |
| Hatipoglu, H; Hatipoglu, N | 1 |
| Amsden, JR; Anaissie, E; Gubbins, PO; McConnell, S | 1 |
| Duettmann, W; Fruhwald, S; Hoenigl, M; Krause, R; Prueller, F; Raggam, RB; Seeber, K; Troppan, K; Valentin, T; Wagner, J; Wölfler, A; Zollner-Schwetz, I | 1 |
| Azzam, R; Katirji, B; Serra, A; Shaikh, AG | 1 |
| Arends, JP; Camps, SM; Debets-Ossenkopp, YJ; Haas, PJ; Kampinga, GA; Karawajczyk, A; Kuijper, EJ; Melchers, WJ; Rijnders, BJ; van der Linden, JW; van Tiel, FH; Varga, J; Verweij, PE; Zoll, J | 1 |
| Bowyer, P; Denning, DW | 1 |
| Bader, O; Buchheidt, D; Christner, M; Groß, U; Held, J; Kuhns, M; Lugert, R; Peter, S; Reichard, U; Schumacher, U; Tintelnot, K; Weig, M | 1 |
| Chowdhary, A; Espinel-Ingroff, A; Gonzalez, GM; Lass-Flörl, C; Martin-Mazuelos, E; Meis, J; Peláez, T; Pfaller, MA; Turnidge, J | 1 |
| Bhaskaran, A; Hosseini-Moghaddam, SM; Husain, S; Rotstein, C | 1 |
| Cicora, F; Mos, F; Paz, M; Roberti, J | 1 |
| Flynn, PM; Hayden, RT; Knapp, KM; Maron, GM; Rodriguez, A; Rubnitz, JE; Shenep, JL | 1 |
| Gnanalingham, K; Nadig, A; Pal, P; Singh, N; Subudhi, CP | 1 |
| Blitz, A; Burger, P; Gallia, G; Ishii, M; Leyngold, I; Olivi, A; Subramanian, PS | 1 |
| Brüggemann, RJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 1 |
| Chen, SC; Meyer, W; Middleton, PG | 1 |
| Cai, J; Chen, S; Cheng, X; Dong, H; Dong, W; Dong, Y; Sun, J; Wang, T; Wang, X; Xing, J; Yao, H | 1 |
| Javed, I; Kotapka, M; Moreno, J; Mynt, MA; Ortiz, J; Vijayvargiya, P; Zaki, R | 1 |
| Dupont, L; Lagrou, K; Maertens, J; Meersseman, P; Saegeman, V; Vermeulen, E | 1 |
| Leroux, S; Ullmann, AJ | 1 |
| Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
| Dominelli, GS; Shaipanich, T | 1 |
| Hirose, Y; Kokuzawa, S; Mochizuki, K; Suemori, S; Yaguchi, T | 1 |
| Gari-Toussaint, M; Roux, C; Thyss, A | 1 |
| Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O | 1 |
| Agbetile, J; Bourne, M; Bradding, P; Brightling, CE; Broad, C; Desai, D; Fairs, A; Green, RH; Haldar, P; Hargadon, B; Morley, J; Pashley, CH; Pavord, ID; Wardlaw, AJ | 1 |
| Badoual, C; Devars Du Mayne, M; El Naderi, S; Rodriguez, C | 1 |
| Ahmad, S; Alkharashi, M; Jun, AS | 1 |
| Halderman, A; Shrestha, R; Sindwani, R | 1 |
| Mavridou, E; Meletiadis, J; Mouton, JW; Siopi, M; Verweij, PE; Zerva, L | 2 |
| Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG | 1 |
| Balasubramanian, S; Dhanakodi, N; Shashidhar, N; Tripathy, SK; Venkataramaiah, S | 1 |
| Ahmed, F; Akhter, S; Hussain, I; Jamil, I; Khawaja, A; Raja, NU; Shohab, D | 1 |
| Bao, ZS; Jiang, T; Li, WB; You, G | 1 |
| Ho, HC; Hsiao, SH; Lee, CY; Tsai, CC | 1 |
| Liu, P; Mould, DR | 2 |
| Cooke, RP; Denning, DW; Ellenbogen, JR; Javadpour, M; Lesser, T; Skinner, DW; Waqar, M | 1 |
| Chowdhary, A; Hagen, F; Meis, JF; Sharma, C | 1 |
| Brüggemann, RJ; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE | 2 |
| Aquino, VR; Bergamasco, MD; Castro, PT; Colombo, AL; Gonçalves, SS; Negri, CE; Xafranski, H | 1 |
| Dolton, MJ; McLachlan, AJ | 1 |
| Chandrasekar, P; Patel, D; Rupali, P | 1 |
| Agarwal, S; Das, A; Gochhait, D; Singh, M; Srinivasan, R; Trehan, A | 1 |
| Denning, DW; Ghnan, N; Kwizera, R; Osmanov, A | 1 |
| Jain, R; Mittal, R; Mittal, V; Sangwan, VS | 1 |
| Becker, A; Desprez, S; Froidure, M; Gagneux, M; Huguet, D; Leduc, D; Legout, L; Sifaoui, F; Vignoli, P | 1 |
| Dannaoui, E; Datry, A; Fekkar, A; Imbert, S; Mazier, D; Meyer, I; Palous, M | 1 |
| Dadzie, CK; Dawis, MA; Kane, S; Pinto, JM | 1 |
| Alffenaar, JW; Kosterink, JG; Rodgers, MG; Span, LF; Uges, DR; van den Heuvel, ER; van der Werf, TS; van Wanrooy, MJ | 1 |
| Barrueta, JA; Charbonneau, C; De Salas-Cansado, M; Gao, X; Garcia-Vidal, C; Jarque, I; Ostermann, H; Solano, C; Stephens, J; Weber, B; Xue, M | 1 |
| Angoulvant, A; Caliandro, R; Fregeville, A; Gossot, D; Stern, JB; Validire, P; Wyplosz, B | 1 |
| Barchiesi, F; Fiorentini, A; Gesuita, R; Mazzanti, S; Mazzocato, S; Singh, N; Skrami, E | 1 |
| Kong, DC; Kotsimbos, T; Levvey, B; Morrissey, O; Neoh, CF; Slavin, MA; Snell, GI; Stewart, K | 1 |
| Açıkalın, A; Arıkan-Akdağlı, S; Erdem, E; Esen, E; İlkit, M; Kandemir, H; Yağmur, M | 1 |
| Zitella, L | 1 |
| Barba-Suñol, P; Blanco-Grau, A; Cabral-Galeano, E; Gavaldà-Santapau, J; Len-Abad, O; Meije-Castillo, Y; Monforte-Torres, V; Pahissa-Berga, A; Pou-Clavé, L; Román-Broto, A; Ruiz-Camps, I; Sordé-Masip, R | 1 |
| Bhat, V; Ganesh, P; Kumar, P; Nagarjuna, M; Salins, PC; Shetty, S | 1 |
| Cornely, OA; Herbrecht, R; Meems, L; Ruhnke, M; van Amsterdam, RG; Viscoli, C | 1 |
| Borders, E; Hopps, S; Roach, A; Yuen, C | 1 |
| Bosschaerts, T; Boulet, G; Cos, P; Fortin, A; Maes, L; Paulussen, C | 1 |
| Bow, EJ; Cornely, OA; Heinz, WJ; Herbrecht, R; Jagannatha, S; Koh, LP; Kontoyiannis, DP; Lee, DG; Maertens, JA; Marr, KA; Nucci, M; Pappas, PG; Queiroz-Telles, F; Rottinghaus, ST; Schlamm, HT; Selleslag, D; Slavin, MA; Walsh, TJ; Wingard, JR | 1 |
| Cotton, D | 1 |
| Arron, ST; Chin-Hong, PV; He, SY; Makhzoumi, ZH; Singer, JP | 1 |
| Bartoli, M; Bulabois, CE; Cahn, JY; Fonrose, X; Gautier-Veyret, E; Quesada, JL; Stanke-Labesque, F; Thiebaut-Bertrand, A; Tonini, J | 1 |
| Chen, L; Liu, K; Liu, Y; Wang, W | 1 |
| Buchheidt, D; Karthaus, M; Kluge, S; Lehrnbecher, T; Lipp, HP | 1 |
| Kamei, K; Kikuchi, K; Ochiai, E; Tamiya, H; Toyotome, T; Watanabe, A; Yaguchi, T; Yahiro, M | 1 |
| Chacko, R; Job, A; Varghese, GM; Varghese, L | 1 |
| Akbayram, S; Bayhan, GI; Garipardic, M; Karaman, K | 1 |
| Ayats, J; Carratalà, J; Cervera, C; de la Bellacasa, JP; Garcia-Vidal, C; Gudiol, C; Moreno, A; Peghin, M; Roselló, E; Royo-Cebrecos, C; Ruiz-Camps, I | 1 |
| Abib, SC; Alves, MT; Carlesse, F; Colombo, AL; Gonçalves, SS; Lederman, HM; Luisi, FA; Marcos, AC; Petrilli, AS; Ricci, G; Seber, A | 1 |
| Bromley, MJ; Denning, DW | 1 |
| Karr, JC; Lauretta, J | 1 |
| Adami, I; Cazzadori, A; Concia, E; Ferrari, S; Forni, A; Mazzaferri, F; Merighi, M; Storato, S; Tocco, P | 1 |
| Goeman, E; Kidd, SE; Meis, JF; Slavin, MA; Verweij, PE | 1 |
| Akers, KS; Chung, KK; Graybill, JC; Mende, K; Murray, CK; Niece, KL; Rowan, MP | 1 |
| Barnes, R; Bow, E; Charbonneau, C; Earnshaw, S; Herbrecht, R; Kantecki, M; Maertens, J; McDade, C; Morrissey, O; Schlamm, H; Slavin, M; Weinstein, D | 1 |
| Meletiadis, J; Siafakas, N; Siopi, M; Vourli, S; Zerva, L | 1 |
| Chang, YC; Eckhaus, MA; Fedorova, N; Figat, A; Joardar, V; Kwon-Chung, KJ; Losada, L; Mounaud, S; Nierman, WC; Pakala, S; Pakala, SB; Sugui, JA; Venepally, P | 1 |
| Annaert, P; Augustijns, P; de Loor, H; Lagrou, K; Maertens, J; Malfroot, A; Mols, R; Spriet, I; Vanstraelen, K | 1 |
| Dominique, S; Favennec, L; Gargala, G; Lavergne, RA; Le Pape, P; Meis, JF; Morio, F; Verweij, PE | 1 |
| Chayakulkeeree, M; Maneerattanaporn, M; Poovipirom, N; Siengwattana, P | 1 |
| Carver, PL; Pettit, NN | 1 |
| Dix, D; Harvey, M; McDonald, A; Sadarangani, M; Speert, DP | 1 |
| Abidi, MZ; D'Souza, A; Hari, P; Kuppalli, K; Ledeboer, N | 1 |
| Gyo, K; Hakuba, N; Hato, N; Okada, M; Okada, Y; Sato, E; Yamada, H | 1 |
| Abid, Q; Hussein, N; Qamar, S | 1 |
| Hanada, Y; Iwasa, N; Kitamura, E; Mizutani, T; Okazaki, T; Shiraishi, S; Yanagihara, T | 1 |
| Ağca, H; Ak, S; Akalın, H; Cilo, BD; Ener, B; Özmerdiven, GE; Tunca, B | 1 |
| Alcazar-Fuoli, L; Buitrago, M; Gomez-Lopez, A; Mellado, E | 1 |
| El-Bardissy, A; El-Mekaty, E; Elewa, H; Ensom, MH; Wilby, KJ | 1 |
| Acharya, N; Lietman, TM; O'Brien, KS; Prajna, L; Prajna, NV; Rose-Nussbaumer, J; Sun, CQ | 1 |
| Costagliola, D; de Castro, N; Denis, B; Guiguet, M; Lortholary, O; Mechaï, F; Melica, G; Revest, M | 1 |
| Andréjak, M; Bennis, Y; Bodeau, S; Bouquié, R; Chouaki, T; Deslandes, G; Gruson, B; Lemaire-Hurtel, AS; Verstuyft, C | 1 |
| Bakker, J; Egal, M; Hunfeld, NG; Koch, BC; van Gelder, T; van Schaik, RH; Weigel, JD | 1 |
| Cha, SA; Chang, KY; Jin, DC; Kim, HH; Kim, HW; Kim, MH; Lim, TS; Park, HS; Wie, SH | 1 |
| Dong, HY; Guo, H; Li, SX; Li, YM; Ma, ZL; Shi, JP; Song, YJ; Zhang, H; Zhang, LL | 1 |
| Chung, MJ; Jeong, JS; Jin, GY; Kim, DS; Kim, SR; Lee, YC | 1 |
| Fasih, N; Irfan, M; Jabeen, K; Rahman, FU; Sharif, H | 1 |
| Bernal-Martínez, L; Cendejas, E; Forastiero, A; Gomez-Lopez, A; Mellado, E | 1 |
| Arron, ST; Asgari, MM; Binstock, M; Boettger, R; Chin-Hong, P; Glidden, D; Golden, J; Hafeez, F; Hays, S; Kim, J; Kukreja, J; Mansh, M; Singer, JP; Williams, K | 1 |
| Barrs, VR; Beatty, JA; Kidd, SE; Martin, P; Talbot, JJ | 1 |
| Maertens, J; Miceli, MH | 1 |
| Gregg, KS; Kauffman, CA | 1 |
| Patterson, TF; Wiederhold, NP | 1 |
| Boyd, AS; Di Pentima, MC; Willis, ZI | 1 |
| Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM | 1 |
| Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S | 1 |
| Aftab, M; Almanfi, A; El-Sayed Ahmed, MM; Frazier, OH; Mallidi, HR; Singh, SK | 1 |
| Aloia, T; Ankoma-Sey, V; Balogh, J; Boktour, M; Fainstein, V; Gaber, AO; Galati, J; Ghobrial, RM; Gordon Burroughs, S; Grimes, KA; Li, XC; McFadden, R; Monsour, HP; Ochoa, RA; Patel, S; Saharia, A; Victor, DW | 1 |
| Dehghan, P; Hashemi, SJ; Melchers, WJ; Mohammadi, F; Rafati, H; Rezaie, S; Seyedmousavi, S; Tamadon, Y; Tolooe, A; van der Lee, HA; Verweij, PE; Zoll, J | 1 |
| Simkins, J | 1 |
| Fukuda, K; Ichiyama, S; Kato, K; Matsumura, Y; Nagao, M; Takakura, S; Yamamoto, M | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Jensen, RH | 1 |
| Cogliati, M; De Lorenzis, G; Esposto, MC; Lazzarini, C; Prigitano, A; Tortorano, AM | 1 |
| Manavathu, EK; Vazquez, JA | 1 |
| Cheng, Y; Liu, Z; Song, X; Su, G; Wang, C; Zhao, J | 1 |
| Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S | 1 |
| Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F | 1 |
| Akoumianaki, T; Albert, N; Andrianaki, A; Chamilos, G; Ioannou, P; Kontoyiannis, DP; Kyrmizi, I; Perlin, D; Samonis, G | 1 |
| Arends, JP; de Brauwer, E; de Greeff, SC; Haas, PJ; Hodiamont, CJ; Kuijper, EJ; Leenstra, T; Lestrade, PP; Meis, JF; Melchers, WJ; Muller, AE; Oude Lashof, AM; Rijnders, BJ; Roelofsen, E; Rozemeijer, W; Tersmette, M; Terveer, EM; van der Beek, MT; van Dijk, K; Verduin, CM; Verweij, PE; Wolfhagen, MJ | 1 |
| Aoun, M; Baddley, JW; Bow, EJ; Cornely, OA; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Kontoyiannis, DP; Lee, DG; Lee, M; Lortholary, O; Maertens, JA; Maher, RM; Marr, KA; Morrison, VA; Neofytos, D; Oren, I; Patterson, TF; Raad, II; Rahav, G; Schmitt-Hoffmann, AH; Selleslag, D; Shoham, S; Thompson, GR; Ullmann, AJ; Zeiher, B | 1 |
| Baietto, L; Bonora, S; Calcagno, A; D'Avolio, A; De Rosa, FG; Motta, I | 1 |
| Bouza, E; Escribano, P; Guinea, J; Kestler, M; López-Fabal, F; Marcos-Zambrano, LJ; Muñoz, P; Peláez, T; Vena, A | 1 |
| Chin-Hong, P; Reid, MJ; Shannon, EM | 1 |
| Agüero, F; Ambrosioni, J; Blanco, JL; Brunet, M; Coll, S; Gatell, JM; Manzardo, C; Miró, JM; Nicolás, D; Tuset, M | 1 |
| Alanio, A; Amazzough, K; Barchiesi, F; Bougnoux, ME; Coignard-Biehler, H; DeWolf, SE; Garcia-Hermoso, D; Jullien, V; Kania, R; Lanternier, F; Lefevre, A; Lortholary, O; Marchionni, E; Parize, P; Poiree, S; Vironneau, P; Wassef, M | 1 |
| Clemons, KV; Hernandez, C; Martinez, M; Moss, RB; Stevens, DA | 1 |
| Alffenaar, JW; Docobo Pérez, F; Hope, W; Huurneman, LJ; Neely, M; Ramos-Martin, V; Tissing, WJ; Veringa, A | 1 |
| Auvergne, L; Ben Ayed, I; Botterel, F; Caballero, MJ; Dhonneur, G; Haouache, H; Hillion, ML; Mongardon, N; Vodovar, D | 1 |
| Baba, H; Baba, Y; Iwatsuki, M; Kurashige, J; Miyamoto, Y; Ohuchi, M; Sakamoto, Y; Shigaki, H; Tokunaga, R; Watanabe, M; Yoshida, N | 1 |
| Chitasombat, MN; Chuwongwattana, S; Dilokpattanamongkol, P; Jantararoungtong, T; Prommas, S; Puangpetch, A; Sukasem, C; Watcharananan, SP | 1 |
| Alffenaar, JW; Encalada Ventura, MA; Kosterink, JG; Rodgers, MG; Span, LF; Uges, DR; van den Heuvel, ER; van der Werf, TS; van Wanrooy, MJ | 1 |
| Fujimoto, M; Gonoi, T; Hagiwara, D; Itoyama, S; Kamei, K; Misawa, Y; Sugahara, M; Takahashi, H; Watanabe, A | 1 |
| Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M | 1 |
| Arora, HS; Bajaj, N; Chadha, D; Hasija, P | 1 |
| Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS | 1 |
| Jiang, M; Li, Y; Liang, X; Liu, J; Nong, G | 1 |
| Azie, N; Franks, B; Goff, D; Horn, D; Khandelwal, N; Shi, F; Shorr, AF; Spalding, J | 1 |
| Boix, H; Camba Longueira, F; Frick, MA; Martin-Gomez, MT; Rodrigo-Pendás, JÁ; Soler-Palacin, P | 1 |
| Aliyali, M; Badali, H; Badiee, P; Hagen, F; Khodavaisy, S; Moazeni, M; Nabili, M; Shokohi, T; Zarrinfar, H | 1 |
| Aguilar, C; Blanchi, S; Bouyer, B; Comacle, P; Hoche-Delchet, C; Le Govic, Y; Penn, P; Sandrini, J | 1 |
| Fujiwara, T; Kida, H; Komatsu, R; Matsumoto, M; Toyotome, T; Wada, T | 1 |
| de Sévaux, RG; Kolwijck, E; Melchers, WJ; Rijstenberg, LL; ten Oever, J; van der Hoeven, H; van der Lee, HA; Verweij, PE; Zoll, J | 1 |
| Durukan, H; Gümral, R; Mutlu, AG; Mutlu, FM; Saracli, MA; Sobaci, G; Yildiran, ST | 1 |
| Ge, T; Li, N; Liao, S; Qi, F; Xu, G; Zhu, L | 1 |
| Kimura, S | 1 |
| Catalán, P; Morales, J; Navea, D; Saias, C; Silva, F; Torres, JP | 1 |
| Cho, SY; Choi, JH; Choi, JK; Choi, SM; Han, S; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Park, C; Park, SH; Yim, DS; Yoo, JH | 1 |
| Ali, SA; Gaur, K; Jagetia, A; Sakhuja, P | 1 |
| D'Anza, B; Greene, JS; Kennedy, T; Sindwani, R; Stokken, J; Woodard, TD | 1 |
| In 't Veld-van Wingerden, AW; Kuijper, EJ; Russcher, A; van Paassen, J; Verweij, PE | 1 |
| Bader, O; Buname, G; Groß, U; Mshana, SE; Mushi, MF | 1 |
| Aram, JA; Capparella, MR; Conte, U; Liu, P; Macias-Parra, M; Martin, JM; Mudry, P; Yan, JL | 1 |
| He, Y; Li, J; Li, JC; Sun, ST; Tao, SY; Wang, LL; Wang, LY; Xu, ZZ; Yu, XF; Zhang, JJ; Zhang, YQ; Zhu, L | 1 |
| Bonney, P; Crawford, D; Gallant, R; Peek, L; Yu, Z | 1 |
| Antal, I; Füredi, P; Kiss, BD; Klebovich, I; Kovács, K; Ludányi, K; Pápay, ZE | 1 |
| Chakrabarti, A; Dhaliwal, M; Meis, JF; Mouton, JW; Rudramurthy, SM; Seyedmousavi, S | 1 |
| Boral, H; Erdem, E; Ersoz, R; Ilkit, M; Seyedmousavi, S; Yagmur, M | 1 |
| Chai, RY; Chen, TK; Finkelman, M; Groncy, PK; Javahery, R; Nagpala, P; Petraitiene, R; Walsh, TJ | 1 |
| Alffenaar, JC; Kosterink, JG; Schölvinck, EH; Ter Avest, M; Tissing, WJ; van den Heuvel, ER; Veringa, A | 1 |
| Azie, N; Harrington, R; Lee, E; Messali, A; Spalding, J; Wei, J; Wu, EQ; Yang, H | 1 |
| Figiel, W; Krawczyk, M; Sulik-Tyszka, B; Wróblewska, M | 1 |
| Long, N; Lu, L; Sang, H; Xu, X; Zeng, Q | 1 |
| Fernandez, J; Nanjappa, S; Pabbathi, S; Srikumar, T | 1 |
| Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ | 1 |
| Matus, I; Nilforoshan, M | 1 |
| Diekema, D; Moye-Rowley, WS; Paul, S | 1 |
| Ikeda, T; Ishikawa, S; Kobayashi, K; Takeyama, H; Tokuda, Y; Wakabayashi, K; Yano, S | 1 |
| Chellamma, T; Cherian, KM; Verghese, S | 1 |
| Ben-Ami, R; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
| Annemans, L; Derde, MP; Marbaix, S; Van Campenhout, H | 1 |
| Ak, Ö; Batırel, A; Demirhan, G; Gençer, S; Özer, S | 1 |
| Baert, K; Beernaert, LA; Chiers, K; De Backer, P; Marin, P; Martel, A; Pasmans, F | 1 |
| Auberger, J; Bellmann, R; Buzina, W; Clausen, J; Gastl, G; Lass-Flörl, C; Nachbaur, D | 1 |
| Alangaden, GJ; Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK | 1 |
| Adani, GL; Baccarani, U; Baraldo, M; Cojutti, P; Franceschi, L; Furlanut, M; Londero, A; Pea, F; Tavio, M; Viale, P | 1 |
| Cordier, JF; Cottin, V; Cristea, D; Meyronet, D; Persat, F | 1 |
| Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK; Revankar, SG | 1 |
| Caira, M; Fianchi, L; Pagano, L | 1 |
| Doorduijn, JK; el Barzouhi, A; Lugtenburg, PJ; Polinder, S; Rijnders, BJ; Slobbe, L; Steyerberg, EW | 1 |
| Donders, AR; Kuijpers, J; Melchers, WJ; Mellado, E; Rijs, AJ; Samson, RA; Snelders, E; van der Lee, HA; Varga, J; Verweij, PE | 1 |
| Hoffman, J; Howard, A; Sheth, A | 1 |
| Bearman, G; Pakyz, A | 1 |
| van Rijswijk, J; van Tol, A | 1 |
| Antonius, T; Brüggemann, RJ; Burger, DM; Heijst, Av; Hoogerbrugge, PM; Warris, A | 1 |
| Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H | 1 |
| Fujita, N; Oyake, M; Sugai, A; Umeda, M; Umeda, Y | 1 |
| Bienvenu, B; Bougnoux, ME; Chandesris, MO; Herman, P; Lanternier, F; Lecuit, M; Lortholary, O; Mamzer, MF; Méchai, F; Mimoun, M; Parize, P; Poirée, S; Viard, JP | 1 |
| Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM | 1 |
| Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B | 1 |
| Baltadakis, I; Karakasis, D; Liapis, K; Manaka, K | 1 |
| Horn, D; Neofytos, D; Sae-Tia, S | 1 |
| Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH | 1 |
| Ayats, J; Fernández, N; Gasch, O; Santin, M | 1 |
| Aşik, G; Ayçiçek, A; Cetinkaya, Z; Kenar, F; Kiraz, N; Kiyici, H | 1 |
| Kida, M | 1 |
| Inagaki, N; Mori, T; Yasuda, H | 1 |
| Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
| Baggen, L; Chisholm, J; Sharland, M; Thomas, L | 1 |
| Segal, BH | 1 |
| Han, FC; Jureen, R; Tew, CW; Tey, BH | 1 |
| Bhavna, B; Kumar, K; Narayan, SK; Roopeshkumar, VR; Swaminathan, RP | 1 |
| Angerer, K; Bonatti, H; Geltner, C; Lass-Floerl, C; Lechner, M; Schmid, T; Singh, N; Singh, R; Stelzmueller, I | 1 |
| Abboud, I; Antoine, C; Benammar, M; Berge, M; Billaud, EM; Glotz, D; Lefeuvre, S | 1 |
| Clemons, KV; Kass, PH; Kline, Y; Martinez, M; Stevens, DA; Tell, LA; Woods, L | 1 |
| Aoyagi, I; Hidaka, H; Katori, Y; Kobayashi, T; Kudo, T; Nakaya, K; Oda, K; Oshima, T; Ota, J | 1 |
| Baert, K; Beernaert, LA; Chiers, K; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L | 1 |
| Laporta, R; Lázaro, MT; Ramos, A; Sánchez-Romero, I; Ussetti, P | 1 |
| Albarrag, A; Anderson, MJ; Arendrup, MC; Cerar, D; Denning, DW; Fisher, MC; Howard, SJ; Laverdiere, M; Pasqualotto, AC; Perlin, DS | 1 |
| Feder, RS; Gupta, G; Lyon, AT | 1 |
| Balajee, SA; Brandt, ME; Gade, L; McCloskey, CB | 1 |
| Genzen, JR; Kenney, B | 1 |
| Bahador, A; Dehghani, M; Gholami, S; Hashemi, SB; Janghorban, P; Kakaei, F; Kazemi, K; Malek-Hosseini, SA; Nikeghbalian, S; Salahi, H; Shishegar, M | 1 |
| George, E; Shinohara, MM | 1 |
| Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M | 1 |
| Fujii, A; Hamano, T; Itoh, H; Kuriyama, M; Matsunaga, A; Naganuma, S; Ueno, A; Yoneda, M | 1 |
| Aloisi, T; Aversa, F; Bonini, A; Caira, M; Candoni, A; Caramatti, C; Cattaneo, C; Chierichini, A; de Waure, C; Fadda, RM; Fanci, R; Ferrara, F; Fianchi, L; Invernizzi, R; Leone, G; Luppi, M; Martino, B; Melillo, L; Mitra, ME; Nosari, A; Offidani, M; Pagano, L; Pastore, D; Picardi, M; Potenza, L; Riva, M; Rossini, F; Specchia, G; Stanzani, M; Vacca, A | 1 |
| Gómez-Bueno, M; Lázaro, MT; Pulpón, L; Ramos, A; Salas, C; Sanchez, I; Segovia, J | 1 |
| Al-Abdely, HM; Al-Tawfiq, JA | 1 |
| In, KH; Kang, EH; Kim, MJ; Yoon, YK | 1 |
| Blanch-Iribarne, P; Garcia-Ramirez, M; Martin-Carballido, S; Martinez-Ferriz, MC; Martinez-Pajares, JD; Moreno-Perez, D | 1 |
| Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S | 1 |
| Jiménez Caballero, PE; Mollejo Villanueva, M | 1 |
| Kumar, P; Matsumoto, C; Pien, E; Rosen, J; Shanmugam, VK; Steen, V; Whelton, S | 1 |
| Barlow, G; Lillie, P; Moss, PJ; Parsonage, MJ; Stafford, ND; Thaker, H | 1 |
| Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W | 1 |
| Borse, N; Jain, V; Natarajan, S; Shome, D | 1 |
| Fuqua, TH; Knoll, M; Said-Al-Naief, N; Sittitavornwong, S | 1 |
| Dirr, F; Ebel, F; Echtenacher, B; Heesemann, J; Hoffmann, P; Wagener, J | 1 |
| Anyfantakis, V; Camus, M; Dammak, A; Delouane, H; Guillet, G; Riche, A; Roblot, F | 1 |
| Hoffman, SB; Smith, LN | 1 |
| de Hoon, J; Meersseman, P; Meersseman, W; Spriet, I; Willems, L | 1 |
| Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Johnson, E; Pelaez, T; Pfaller, MA; Rinaldi, MG; Turnidge, J | 1 |
| McCormack, J; Pollard, J | 1 |
| Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y | 1 |
| Aversa, F; Caira, M; Candoni, A; Leone, G; Luppi, M; Martino, B; Nosari, A; Offidani, M; Pagano, L; Specchia, G; Tosti, ME; Valentini, CG | 1 |
| Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
| Bowyer, P; Bueid, A; Denning, DW; Harrison, E; Howard, SJ; Moore, CB; Richardson, MD | 1 |
| Ehlert, K; Fegeler, W; Groll, AH; Kerl, K; Koch, B; Rossig, C | 1 |
| Atalay, H; Erekul, S; Nar, A; Ozbek, O; Solak, Y; Turk, S; Turkmen, K | 1 |
| Bello, I; Golmia, R; Hamerschlak, N; Marra, A; Osawa, A; Scheinberg, M | 1 |
| Jiang, HR; Wu, XG; Xin, M; Yang, LN | 1 |
| Amrein, C; Beaune, PH; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Laurent-Puig, P; Le Beller, C; Lillo-Lelouet, A; Loriot, MA; Trégouet, DA | 1 |
| Bellmann, R; Bellmann-Weiler, R; Dunzendorfer, S; Fiegl, D; Joannidis, M; MacFarland, R; Stienecke, E; Weiler, S | 1 |
| Higaki, T; Itokawa, T; Kami, M; Komatsu, T; Miura, Y; Murashige, N; Murata, K; Takei, N; Tsubokura, M | 1 |
| Falcone, M; Massetti, AP; Russo, A; Venditti, M; Vullo, V | 1 |
| Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E | 1 |
| Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H | 1 |
| Durrani, OM; Joganathan, V; Mehta, P; Oppenheim, B | 1 |
| Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Nieminen, TH; Olkkola, KT; Saari, TI | 1 |
| Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M | 1 |
| Giguère, P; Kravcik, S; la Porte, CJ; Toy, J | 1 |
| Jones, B; Lang, S; Lappin, DF; Majithiya, JB; McCulloch, E; Mowat, E; Rajendran, R; Ramage, G; Warn, P; Williams, C | 1 |
| Bouza, E; Escribano, P; Guinea, J; Peláez, T; Recio, S | 1 |
| Hao-Ran, J; Li-Na, Y; Meng, X; Xiang-Gen, W | 1 |
| Azim, S; Fadoo, Z; Manzoor, NF | 1 |
| Actis Dato, GM; Bardi, G; Casabona, R; Del Ponte, S; Flocco, R; Forsennati, P; Parisi, F; Punta, G; Sansone, F; Zingarelli, E | 1 |
| Agarwal, P; Sharma, N; Sinha, R; Titiyal, JS; Vajpayee, RB; Velpandian, T | 1 |
| Katragkou, A; Roilides, E | 1 |
| Caira, M; Fianchi, L; Pagano, L; Valentini, CG | 1 |
| Reisman, A; Schwartz, S; Troke, PF | 1 |
| Arendrup, MC; Fuursted, K; Gahrn-Hansen, B; Howard, SJ; Jensen, RH; Johansen, HK; Knudsen, JD; Mortensen, KL | 1 |
| Dong, X; Min, X; Wu, X; Xie, L; Yang, L | 1 |
| Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L | 1 |
| Aki, ŞZ; Akyürek, N; Şenol, E; Sucak, G; Tunçcan, ÖG | 1 |
| Bajaj, MS; Kashyap, S; Meel, R; Pushker, N; Sen, S | 1 |
| George, J; Reboli, AC | 1 |
| Jang, IJ; Kim, KH; Kim, NJ; Lee, S; Oh, MD; Park, WB; Yu, KS; Yun, NR | 1 |
| Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M | 1 |
| Miller, CJ; Seykora, JT; Shinohara, MM | 1 |
| Stirbu, O; Suriano, MM; Vila Arteaga, J | 1 |
| Clifton, IJ; Conway, SP; Metcalfe, R; Peckham, DG; Phillip, M; Shaw, N; Whitaker, P | 1 |
| Choi, JH; Choi, SM; Han, S; Kim, SH; Kwon, EY; Kwon, JC; Lee, DG; Park, C; Park, SH; Yim, DS; Yoo, JH | 1 |
| Afshari, NA; Goldhagen, BE; Majka, CP; Perfect, JR; Rebong, RA; Santaella, RM; Steinbach, WJ | 1 |
| Beguin, H; Detandt, M; Hendrickx, M | 1 |
| Aoun, M; Gadisseur, A; Jacobs, F; Selleslag, D; Sonet, A | 1 |
| Bouza, E; Escribano, P; González-Rivera, M; Guinea, J; Peláez, T; Recio, S | 1 |
| Blosser, SJ; Cramer, RA | 1 |
| Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Bahlaoui, A; Bakhatar, A; Chakib, A; El Fane, M; El Filali, KM; Ouladlahsen, A; Sodqi, M | 1 |
| Hope, WW | 1 |
| Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L | 1 |
| Wintenberger, C | 1 |
| Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Salas, V | 1 |
| Gyotoku, H; Ikeda, H; Imamura, Y; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, T; Kohno, S; Miyazaki, T; Miyzaki, Y; Morinaga, Y; Nakamura, S; Nishino, T; Ohno, H; Takazono, T; Yaguchi, T; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Bouza, E; Giannella, M; Guinea, J; Klaassen, CH; Muñoz, P; Peláez, T; Valerio, M | 1 |
| Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ | 1 |
| Bu, D; Chen, W; Li, R; Liu, W; Sun, Y; Wan, Z | 1 |
| Mavridou, E; Melchers, WJ; Meletiadis, J; Mouton, JW; Verweij, PE | 1 |
| Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V | 1 |
| Bergeron, A; Ferry, C; Lacroix, C; Peffault de Latour, R; Petropoulou, A; Porcher, R; Ribaud, P; Robin, M; Rocha, V; Salmeron, G; Socié, G; Sulahian, A; Xhaard, A | 1 |
| Couderc, L; Dominique, S; Favennec, L; Leguillon, C; Marguet, C; Masseline, B; Pramil, S; Rondeau, S | 1 |
| Cook, G; Cordonnier, C; Hicheri, Y | 1 |
| Mittal, R; Mittal, V | 1 |
| Buresova, L; Cetkovsky, P; Kocmanova, I; Kouba, M; Lengerova, M; Malaskova, L; Mayer, J; Racil, Z; Rolencova, M; Timilsina, S; Toskova, M; Weinbergerova, B; Winterova, J; Zak, P | 1 |
| Barreiro, GC; Leite, PF; Samano, MN; Siciliano, RF; Strabelli, TM; Tuma Júnior, P; Waisberg, DR | 1 |
| Biswas, J; Gopal, L; Selvakumar, P; Sofia, O | 1 |
| Corso, V; Drudi, F; Fantini, M; Imola, M; Mianulli, AM; Pasini, G; Ravaioli, A; Santelmo, C; Veneroni, L | 1 |
| Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E | 1 |
| Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP | 1 |
| Kuroki, K; Murakami, T | 1 |
| Andes, DR; Baddley, JW; Boeckh, M; Brizendine, KD; Chiller, T; Ito, JI; Kauffman, CA; Kontoyiannis, DP; Lyon, GM; Marr, KA; Oster, RA; Pappas, PG; Patterson, TF; Schuster, MG | 1 |
| Alanio, A; Bretagne, S; Brisse, S; Cabaret, O; Cordonnier, C; Costa, JM; Sitterlé, E | 1 |
| Ganesan, P; Philip, A; Sagar, TG; Sivaprakasam, P | 1 |
| Fukushima, K; Goto, H; Miharu, M; Mori, M; Shoji, S; Yoshida, M | 1 |
| Kema, GH; Melchers, WJ; van de Sande-Bruisma, N; Verweij, PE | 1 |
| Choe, PG; Jang, IJ; Kim, KH; Kim, NH; Kim, NJ; Lee, SH; Nam, WS; Oh, MD; Park, WB; Song, KH; Yoon, SH; Yu, KS | 1 |
| Deniz, K; Karakukcu, M; Ozdemir, MA; Patiroglu, T; Tucer, B; Unal, E; Yikilmaz, A | 1 |
| Becce, F; Lecouvet, FE; Malghem, J; Omoumi, P; Vande Berg, BC | 1 |
| Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
| Andersen, CB; Carlsen, J; Iversen, M; Jensen, C; Tofte, N; Tvede, M | 1 |
| Egli, A; Fuller, J; Humar, A; Kapasi, A; Kumar, D; Lien, D; Nador, R; Weinkauf, J | 1 |
| Grimault, A; Lyoen, M; Minello, A; Rostain, F; Sgro, C | 1 |
| Clark, LP; Folio, L; Henderson, CM; Holland, SM; Kwon-Chung, KJ; Nardone, G; Peterson, SW; Riedlinger, G; Shea, Y; Sugui, JA; Zelazny, AM; Zerbe, CS | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Denning, DW; Felton, S; Haylett, AK; Rhodes, LE | 1 |
| Choi, SH; Hwang, JY; Kim, YJ; Koo, HH; Lee, SH; Lee, SY; Sung, KW; Yoo, KH | 1 |
| Bhavan, KP; Boyd, NK; Swancutt, MA; Zoellner, CL | 1 |
| Huang, XE; Shen, ZS; Su, AL; Xu, YL; Zhang, XQ; Zhang, XZ | 1 |
| Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, PS; Lietman, TM; Mascarenhas, J; Oldenburg, CE; Porco, TC; Prajna, VN; Srinivasan, M; Sy, A; Vaitilingam, CM | 1 |
| Curtis, LT | 1 |
| Bos, B; Buchheidt, D; Cornely, OA; Halbsguth, TV; Hallek, M; Hamprecht, A; Kahl, P; Kutsch, N; Persigehl, T; Plum, G; Spiess, B; Steinbach, A; Stippel, D; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Cherian, T; Giakoustidis, A; Heaton, DN; Heneghan, M; O'Grady, J; Rela, M; Verma, A; Wendon, J; Yokoyama, S | 1 |
| Auzinger, G; Bernal, W; Heneghan, MA; López, JC; Solís-Muñoz, P; Verma, A; Wendon, J; Willars, C | 1 |
| Fiehler, J; Gerloff, C; Kruetzelmann, A; Rosenkranz, M; Sobottka, I; Tolosa, E | 1 |
| Choi, YL; Joo, H; Kang, SW; Kim, E; Kim, TH; Kim, YH; Park, SJ; Shin, JG; Son, JH; Song, IS; Yoon, YC | 1 |
| Bojtarova, E; Cetkovsky, P; Drgona, L; Foralova, R; Forsterova, K; Guman, T; Haber, J; Kandrnal, V; Kocmanova, I; Kouba, M; Mallatova, N; Masarova, L; Mayer, J; Mudry, P; Muzik, J; Racil, Z; Sejnova, D; Tothova, E; Vydra, J; Weinbergerova, B; Ziakova, B | 1 |
| Bartelink, IH; Bierings, M; Boelens, JJ; de Waal, M; Egberts, TC; Jonker, M; Ververs, TT; Wolfs, T | 1 |
| Brüggemann, RJ; Melchers, WJ; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE | 1 |
| Allisy, C; Bougnoux, ME; Charlier, C; Hermine, O; Lecuit, M; Lortholary, O; Roth, P; Shoai Tehrani, M; Sicre de Fontbrune, F | 1 |
| Boehme, A; Egerer, G; Greiner, J; Heinz, WJ; Lellek, H | 1 |
| Aversa, F; Cesaro, S; de Rosa, FG; Girmenia, C; Micozzi, A; Mikulska, M; Novelli, A; Sanguinetti, M; Viscoli, C | 1 |
| Autmizguine, J; Krajinovic, M; Litalien, C; Marquis, C; Ovetchkine, P; Rousseau, J; Tapiéro, B; Théorêt, Y | 1 |
| Hoenigl, M; Krause, R | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Salas, V; Sutton, DA | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Husain, S; Luong, ML; Rotstein, C | 1 |
| Askew, DS; Bick, G; Feng, X; Krishnan, K; Powers-Fletcher, MV; Richie, DL; Woollett, LA | 1 |
| Abe, K; Arakawa, H; Ishida, T; Notani, H; Ookubo, Y; Suto, C | 1 |
| Danner, RL; Figg, WD; Henning, SA; Jarosinski, PF; Moriyama, B; Penzak, SR; Walsh, TJ; Wayne, AS | 1 |
| Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA | 1 |
| Coco, BJ; Kirkpatrick, WR; Patterson, TF; Perea, S | 1 |
| Bennett, JE; Caillot, D; Chandrasekar, PH; de Pauw, B; Denning, DW; Durand, C; Greene, RE; Herbrecht, R; Hodges, MR; Kern, WV; Lortholary, O; Marr, KA; Oestmann, JW; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Stark, P; Sylvester, R; Thiel, E; Troke, PF; Wingard, JR | 1 |
| Fothergill, AW; Gonzalez, G; Kirkpatrick, WR; Patterson, TF; Perea, S; Rinaldi, MG | 1 |
| Brown, NE; Chow, L; Kunimoto, D | 1 |
| Brown, J; Potoski, BA | 1 |
| Goa, KL; Muijsers, RB; Scott, LJ | 1 |
| Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
| Blot, F; Edé, C; Nitenberg, GM | 1 |
| Karthaus, M | 1 |
| Johnson, LB; Kauffman, CA | 1 |
| Herbrecht, R | 1 |
| Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A | 1 |
| Ruhnke, M | 1 |
| de la Torre-Cisneros, J; DuPont, B; Espinel-Ingroff, A; Greenberg, RN; Johnson, E; Just-Nübling, G; Lutsar, I; Marr, KA; Perfect, JR; Schlamm, HT; Walsh, TJ | 1 |
| Mori, T | 1 |
| Johnson, PD; Korman, TM; Stratov, I | 1 |
| Harris, GJ; Kim, JE; Perkins, SL | 1 |
| Feldmesser, M; Pamer, EG; Van Epps, HL | 1 |
| Alvarez, ME; Fortún, J; Martín-Dávila, P; Moreno, S; Pintado, V; Sánchez, MA; Sánchez-Sousa, A | 1 |
| Ullmann, AJ | 1 |
| Fung, HB; Jeu, L; Lyakhovetskiy, AG; Piacenti, FJ | 1 |
| Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E | 1 |
| Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L | 1 |
| Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Auner, HW; Dornbusch, HJ; Eibl, M; Linkesch, W; Sill, H; Zinke-Cerwenka, W | 1 |
| Garbino, J; Kolarova, L; Lew, D; Ondrusova, A; Rohner, P | 1 |
| Denning, D; Guiver, M; Sambatakou, H | 1 |
| Chávez, M; Claro, R; Espinel-Ingroff, A; Mazuelos, EM; Morilla, D; Ramírez, M; Serrano, MC; Valverde, A | 1 |
| Sims-McCallum, RP | 1 |
| Bilger, K; D'incan, E; Damaj, G; Doglio, MF; Faucher, C; Gastaut, JA; Ivanov, V; Le Brigand, B; Vey, N | 1 |
| Chow, E; Moore, T; Nielsen, K | 1 |
| Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH | 1 |
| Denning, DW; Hope, WW | 1 |
| Alangaden, GJ; Baskaran, I; Chandrasekar, PH; Manavathu, EK; Varanasi, NL | 1 |
| Díaz, MA; González-Vicent, M; Lassaletta, A; Madero, L; Perez, A; Sevilla, J | 1 |
| Caliandro, R; Girard, P; Stern, JB | 1 |
| Baden, LR; Cosimi, LA; Marty, FM | 1 |
| Dupont, B | 1 |
| Bastié, JN; Bretagne, S; Castaigne, S; Chehata, S; Cordonnier, C; Kuentz, M; Maury, S; Pautas, C; Ribaud, P | 1 |
| Contu, L; La Nasa, G; Ledda, A; Littera, R; Maccioni, A; Vacca, A | 1 |
| Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T | 1 |
| Aliyeva, SE; Frising, M; Kottler, UB; Schwenn, O; Ullmann, AJ | 1 |
| Schwartz, S; Thiel, E | 2 |
| Smilack, JD; Sohail, MR | 1 |
| Rubin, ZA; Somani, J | 1 |
| Basso, C; Biffanti, R; Milanesi, O; Stellin, G; Thiene, G; Vida, V | 1 |
| Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
| Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A | 1 |
| Antoniades, A; Giotakis, J; Imbrios, G; Manesis, EK; Tsiodras, S; Zafiropoulou, R | 1 |
| Peetermans, WE; Van Wijngaerden, E; Vandecasteele, SJ | 1 |
| Benjamin, DK; Jafri, H; Kontoyiannis, DP; Lionakis, MS; Lutsar, I; Marr, KA; Perfect, JR; Steinbach, WJ; Torres, HA; Walsh, TJ | 1 |
| Balajee, SA; Englund, JA; Fredricks, DN; Imhof, A; Marr, KA | 1 |
| Bouteille, B; Debette-Gratien, M; Denes, E; Gaulier, JM; Pichon, N | 1 |
| Bonatti, H; Dierich, MP; Freund, MC; Gastl, G; Gschwendtner, A; Gunsilius, E; Kropshofer, G; Lass-Flörl, C; Petzer, A | 1 |
| Chandrasekar, PH; Cutright, JL; Manavathu, EK | 2 |
| Gavaldá, J; Lumbreras, C | 1 |
| Azzola, A; Bubendorf, L; Eich, G; Gratwohl, A; Habicht, JM; Passweg, JR; Tamm, M | 1 |
| Boeckh, M; Carter, RA; Corey, L; Kim, HW; Marr, KA | 1 |
| Viscoli, C | 1 |
| Boyd, AE; Denning, DW; Howard, SJ; Keevil, BG; Modi, S; Moore, CB | 1 |
| Fujisaki, G; Kami, M; Kishi, Y; Kobayashi, K; Mitamura, T; Murashige, N | 1 |
| Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ | 1 |
| Beltramo, D; Levin, T; Samuel, R; Suh, B | 1 |
| Friedman, GS; Mathis, AS; Shah, NK | 1 |
| Perfect, JR | 1 |
| Marr, K | 1 |
| Birnbaum, DE; Jagiello, M; Liebold, A; Retzl, G; Wieland, T | 1 |
| Clezy, K; van Hal, SJ | 1 |
| Balwierz, W | 1 |
| Belohradsky, BH; Führer, M; Graubner, UB; Kammer, B; Moelter, C; Schmid, I; Schuster, F | 1 |
| Del Favero, A; Kibbler, C; Marciniak, A; Mauskopf, J; Morris, S; Rogers, T; Rotstein, C; Schlamm, H; Troke, P; Wenzel, R | 1 |
| Dupont, B; Fain, O; Herbrecht, R; Lescure, FX; Lortholary, O; Lutsar, I; Mouas, H | 1 |
| Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J | 1 |
| Cesaro, S; Visintin, G | 1 |
| Chaberny, IF; Fischer, S; Gastmeier, P; Gottlieb, J; Haubitz, B; Mattner, F; Mattner, L; Strueber, M; Weissbrodt, H | 1 |
| Ermert, L; Lohmeyer, J; Lommel, D; Ludwig, M; Schneider, H; Sziegoleit, A; Weidner, W | 1 |
| Christmann, D; Eisenmann, B; Forestier, E; Hansman, Y; Lesens, O; Martinot, M; Remy, V | 1 |
| Cuenca-Estrella, M; Elia, M; Gutierrez, F; Masia, M; Ramos, JM; Rodriguez-Tudela, JL | 1 |
| Leather, H | 1 |
| Brown, J; Freeman, BB | 1 |
| Böhme, A; Haas, A; Maschmeyer, G | 1 |
| Ambegaonkar, AJ; Boucher, HW; Day, DL; Lewis, JS; Lubowski, TJ; Patterson, TF | 1 |
| Kofla, G; Ruhnke, M | 1 |
| Corey, L; Cornely, OA; Driscoll, T; Lutsar, I; Ribaud, P; Ruhnke, M; Schuler, U; Schwartz, S; Thiel, E; Troke, P | 1 |
| Athanassiadou, F; Kalogera, A; Kourti, M; Papageorgiou, T; Tragiannidis, A; Velegraki, A | 1 |
| Bedini, A; Cocchi, S; Codeluppi, M; Esposito, R; Guaraldi, G; Squillace, N; Venturelli, C | 1 |
| Barton, TD; McGarvey, M; Milas, B; Pochettino, A; Reboli, A; Reis, LJ; Schuster, MG; Velazquez, O | 1 |
| MacCallum, DM; Odds, FC; Whyte, JA | 1 |
| Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C | 1 |
| Bergeron, A; Dromer, F; Ferry, C; Feuilhade, M; Gluckman, E; Hermoso, DG; Lacroix, C; Molina, JM; Pavie, J; Ribaud, P; Robin, M | 1 |
| Steinbach, WJ | 1 |
| Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A | 1 |
| Bennett, JE; Boucher, HW; Denning, DW; DePauw, B; Herbrecht, R; Lortholary, O; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Troke, P; Wingard, JR | 1 |
| Blijlevens, NM; Jansen, JP; Meis, JF; van't Wout, JW | 1 |
| Balfour-Lynn, I; Buchdahl, R; Bush, A; Davies, J; Edwards, S; Francis, J; Hilliard, T; Rosenthal, M | 1 |
| Ballentine, CS; Glickman, RD; Graybill, JR; Harrison, JM; Kumar, N; Kurian, P; Lloyd, WC; Melendez, R; Miller, A; Miller, MM; Najvar, LK; Paris, G; Patel, AH; Pena, MA; Sponsel, WE; Trigo, Y; Trujillo, F | 1 |
| Blatny, J; Burgetova, D; Kren, L; Mudry, P; Prochazka, J; Skotakova, J; Sterba, J; Valik, D; Ventruba, J | 1 |
| Schoeni, MH | 1 |
| Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
| Devouassoux, G; Freymond, N; Harf, R; Le Loch, JB; Pacheco, Y; Rakotomalala, A | 1 |
| Nagino, K; Shirasawa, H | 1 |
| Decosterd, LA; Duchosal, MA; Gambillara, E; Kovacsovics, T; Laffitte, E; Panizzon, RG; Widmer, N | 1 |
| Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY | 1 |
| Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA | 1 |
| Carpenter, J; Howell, A; Hurley, D; Midturi, J; Sierra-Hoffman, M; Winn, R | 1 |
| Curigliano, G; de Braud, F; De Pas, T; Fazio, N; Formica, V; Goldhirsch, A; Pietri, E; Spitaleri, G | 1 |
| Kumar, R; Naithani, R | 1 |
| Denning, DW; Jain, LR | 1 |
| Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Marik, PE; Raman, T | 1 |
| Alarcón L, P; Camacho A, J; Cruces R, P; Donoso F, A | 1 |
| Aguado, JM; Del Busto, R; Fisher, RA; Forrest, G; Houston, S; Husain, S; Klintmalm, GB; Kontoyiannis, DP; Lewis, RE; Limaye, AP; Miller, R; Montoya, JG; Muñoz, P; Patton, P; Pursell, K; Rosso, F; Safdar, N; Singh, N; Wagener, MM | 1 |
| Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S | 1 |
| Badet, M; Bayle, F; Guérin, C; Lemasson, S; Philit, F; Poupelin, JC; Richard, JC | 1 |
| Coco, BJ; Kirkpatrick, WR; Patterson, TF | 1 |
| Allamani, M; Falagas, ME; Michalopoulos, A; Vassiloyanakopoulos, A | 1 |
| Ada, E; Avkan Oğuz, V; Balci, P; Ceylan, E; Gülşen, A; Güngör, O; Kargi, A; Sanli, A; Tertemiz, KC; Uçan, ES; Uğural Sezak, N | 1 |
| Cobb, S; Diekema, DJ; Hoth, P; Magalheas-Silverman, M; Pfaller, MA; Polgreen, PM; Siwek, GT | 1 |
| Hasan, Y; Stableforth, P; Wandroo, F | 1 |
| Braun-Falco, M; Ring, J | 1 |
| Axer-Siegel, R; Bishara, J; Blau, H; Kramer, M; Kramer, MR; Weinberger, D | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Akova, M; Sahin, GO | 1 |
| Aperis, G; Mylonakis, E | 1 |
| Denning, DW; Dupont, B; Lode, H; Sambatakou, H | 1 |
| Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J | 1 |
| Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE | 1 |
| Clemons, KV; Martinez, M; Parmar, R; Stevens, DA | 1 |
| Agarwal, R; Singh, N | 1 |
| Edwards, C; Garcia, RJ; Troya, P | 1 |
| Blackwood, RA; Klein, KC | 1 |
| Carby, M; Hall, AV; Zoumot, Z | 1 |
| Almyroudis, NG; Bhatti, Z; Segal, BH; Shaukat, A | 1 |
| Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H | 1 |
| Bäsecke, J; Glass, B; Perske, C; Rüchel, R | 1 |
| Bal, AM | 1 |
| Eifinger, F; Frankenbusch, K; Kribs, A; Rengelshauseu, J; Roth, B | 1 |
| Dikman, S; Huprikar, S; Linden, E; Murphy, B; Restrepo, D | 1 |
| Gottfredsson, M; Steingrímsdóttir, H | 1 |
| Kadota, J; Tokimatsu, I | 1 |
| Hapuarachchi, S; Jayasinghe, S; Perera, KN; Ranwala, R; Rodrigo, N; Warnakulasuriya, A | 1 |
| Bailey, TA; Di Somma, A; Silvanose, CD | 1 |
| Klastersky, J; Paesmans, M | 1 |
| Cornely, OA; Glöckner, A | 1 |
| Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
| Bouges-Michel, C; Dannaoui, E; Garcia-Hermoso, D; Lortholary, O; Meneau, I; Naccache, JM; Sanglard, D; Valeyre, D | 1 |
| Alvarez-Lerma, F; Grau, S; Marín-Casino, M; Mateu-De, AJ; Torres-Rodríguez, JM | 1 |
| De Stefano, V; Fianchi, L; Leone, G; Murri, R; Pagano, L; Rossi, E | 1 |
| Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I | 1 |
| Crespo, M; Husain, S; Johnson, B; Kwak, EJ; McCurry, KR; Pakstis, DL; Paterson, DL; Pilewski, J; Shutt, K; Studer, S; Zaldonis, D; Zeevi, A | 1 |
| Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA | 1 |
| Donati, A; Gabbanelli, V; Nataloni, S; Pantanetti, S; Pelaia, P; Rossi, R | 1 |
| Garbino, J; Roberts, C; Schnetzler, G | 1 |
| Honda, M; Ichiyasu, H; Kohrogi, H; Matsumoto, M; Okamoto, S; Okamoto, T; Sato, K; Tsumori, K; Yamamura, A | 1 |
| Baumann, A; Caversaccio, M; Hausler, R; Zimmerli, S | 1 |
| Araujo, R; Pina-Vaz, C; Rodrigues, AG | 1 |
| Hasegawa, Y; Hitomi, S; Imagawa, S; Ishii, Y; Kaneko, S; Kojima, H; Machino, T; Mukai, HY; Muto, H; Nagasawa, T; Okoshi, Y; Suzukawa, K | 1 |
| Del Castillo, A; Díaz, S; Domínguez-Gil, A; García Vargas, M; Martín, I; Sánchez, C | 1 |
| Baden, LR; Katz, JT; Koplan, BA; Marty, FM; Philips, JA; Stone, RM | 1 |
| Boumediene, A; Darde, ML; Denes, E; Durox, H; Gaulier, JM; Oksman, A; Saint-Marcoux, F | 1 |
| Lambert, JS; Poulton, MB; Scott, CJ; Taylor, CB | 1 |
| Mylona, S; Ntai, S; Pomoni, M; Thanos, L; Tzavara, V | 1 |
| Melchers, WJ; Mellado, E; Verweij, PE | 1 |
| Benjamin, DK; Jafri, HS; Mejias, A; Patel, S; Sánchez, PJ; Santos, RP; Walsh, TJ | 1 |
| Handa, H; Irisawa, H; Karasawa, M; Matsushima, T; Murakami, H; Nojima, Y; Saitoh, T; Shimizu, H; Tsukamoto, N; Yokohama, A | 1 |
| Ajisawa, A; Honma, M; Imamura, A; Negishi, M; Suganuma, A; Suzuki, T; Takeshita, N; Yanagisawa, N | 1 |
| Bonatti, H; Lass-Floerl, C; Lechner, M; Lorenz, I; Piza, H; Rieder, J; Rieger, M | 1 |
| Fincher, T; Fulcher, SF | 1 |
| Kontoyiannis, DP; Lewis, RE | 1 |
| Ament, AJ; de Groot, R; Donnelly, JP; Hübben, MW; Severens, JL; van 't Wout, J; Verweij, PE; Warris, A | 1 |
| Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y | 1 |
| Ishida, H; Kanda, F; Kuga, A; Oishi, K | 1 |
| Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J | 1 |
| Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A | 1 |
| Eschertzhuber, S; Hoefer, D; Hoermann, C; Lass-Florl, C; Velik-Salchner, C | 1 |
| Herbrecht, R; Marciniak, A; Mauskopf, J; Roberts, CS; Schlamm, HT; Wingard, JR | 1 |
| Kaye, SB; Neal, TJ; Quah, SA; Stewart, RM | 1 |
| Hamanaka, N; Hiroi, N; Homma, S; Isobe, K; Kikuchi, N; Kimura, K; Muraoka, S; Shibuya, K; Shimizu, K; Sugino, K; Takai, Y; Yamazaki, Y | 1 |
| Bongiovanni, M; Chalandon, Y; Meyer, M; Pache, JC; Van Delden, C; Waldvogel, S | 1 |
| Haas, A; Maschmeyer, G | 1 |
| Granowitz, E; Iarikov, D; Robertson, D; Skiest, D | 1 |
| Foo, H; Gottlieb, T | 1 |
| Bailey, T; Demiraj, F; Di Somma, A; Krautwald-Junghanns, ME; Schmidt, V; Ungemach, FR | 1 |
| Fujita, M; Harada, E; Ikegame, S; Inoshima, I; Nakanishi, Y; Ouchi, H | 1 |
| Kauffman, CA; Malani, AN | 1 |
| Guarro, J; Pastor, FJ | 1 |
| Denning, DW | 1 |
| Jain, A; Sun, Y; Ta, CN | 1 |
| Calvo, C; de Andoin, NG; Guerrero, R; Landa, J; Nogues, A; Onate, E; Uriz, J | 1 |
| Kaya, AD; Kiraz, N | 1 |
| Dambrin, C; Durand, D; Garrouste, C; Kamar, N; Linas, MD; Rostaing, L; Tall, P; Wéclawiak, H | 1 |
| Hamada, S; Iwasaki, Y; Izumi, N; Kamoshima, Y; Okugawa, S; Sawamura, Y | 1 |
| Feldberg, E; Halperin, D; Lahav, J; Warman, M | 1 |
| Bergeron, A; de Latour, RP; Devergie, A; Ferry, C; Ghannoum, M; Gluckmana, E; Lacroix, C; Lapalu, J; Madureira, A; Ribaud, P; Robin, M; Rocha, V; Socié, G | 1 |
| Stratakos, G; Zakynthinos, S | 1 |
| Greene, RE; Mauskopf, J; Roberts, CS; Schlamm, HT; Zyczynski, T | 1 |
| Endo, I; Matsuo, K; Morioka, D; Moroboshi, T; Sekido, H; Shimada, H; Takeda, K; Togo, S | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Meessen, NE; Oosten, AW; Sprenger, HG; van Assen, S; van Leeuwen, JT | 1 |
| Cimino, G; Gentile, G; Girmenia, C; Martino, P; Pizzarelli, G; Pozzi, E | 1 |
| Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A | 1 |
| Fujishima, T; Hashimoto, M; Honda, Y | 1 |
| Arnaud, P; Desmonts, JM; Lasocki, S; Massias, L; Montravers, P; Papy, E; Quintard, H | 1 |
| Jones, A; Muhtaseb, M | 1 |
| Denning, DW; Pasqualotto, AC; Shah, M; Wynn, R | 1 |
| Fabré, G; Maes, B; Peetermans, WE; Van Dorpe, J; Vanacker, A | 1 |
| Akhaddar, A; Albouzidi, A; Boucetta, M; Elmostarchid, B; Gazzaz, M; Lmimouni, B | 1 |
| de la Fuente-Trabado, M; Díaz, MA; González-Vicent, M; Lassaletta, A; López-Pino, MA; Romero-Tejada, JC | 1 |
| Amrein, C; Bergé, MM; Billaud, EM; Boussaud, V; Chevalier, P; Daudet, N; Guillemain, R; Le Beller, C; Lillo-Le Louet, A | 1 |
| Golinval, O; Louis, R | 1 |
| Herbrecht, R; Ribaud, P; Schlamm, HT; Wingard, JR | 1 |
| Bailey, T; Di Somma, A; Garcia-Martinez, C; Silvanose, C | 1 |
| Chirch, L; Fuhrer, J; Roche, P | 1 |
| Can, MF; Cetiner, S; Gorenek, L; Ozerhan, I; Tozkoparan, E; Yagci, G | 1 |
| Joshi, R; Kohli, V; Sachdev, P; Taneja, V | 1 |
| Begueret, H; Beylot-Barry, M; Couprie, B; Domergue, V; Doutre, MS; Huerre, M; Orlandini, V; Tunon de Lara, M | 1 |
| Athan, E; Campbell, P; Chang, CC; Cheng, AC; Devitt, B; Hughes, AJ; Low, J; Styles, K | 1 |
| Goel, M; Prakash, G; Sharma, N; Titiyal, JS; Vajpayee, RB | 1 |
| Kohno, S; Kurashima, A; Maesaki, S; Niki, Y; Ogawa, K | 1 |
| Mavinkurve-Groothuis, AM; van Die, LE; van't Hek, LG; Verweij, PE; Warris, A; Zwitserloot, AM | 1 |
| Andriole, VT; George, D; Miniter, P | 1 |
| Hitchcock, CA; Martin, MV; Yates, J | 1 |
| Milatovic, D; Schwartz, S; Thiel, E | 1 |
| de Sévaux, RG; Kullberg, BJ; Meis, JF; van de Nes, JA; van der Meer, JW; Verweij, PE | 1 |
| Meis, JF; van 't Hek, LG; van Dalen, R; Verweij, PE; Weemaes, CM; Yntema, JB | 1 |
| Brinkman, K; Kremer, HP; Kullberg, BJ; Meis, JF; Verweij, PE | 1 |
| Fothergill, AW; Revankar, SG; Rinaldi, MG; Sanche, SE; Sutton, DA | 1 |
| Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH | 1 |
| Chandrasekar, PH; Cutright, J; Manavathu, E | 1 |
| Niki, Y | 1 |
| Chandrasekar, PH; Cutright, JL; Loebenberg, D; Manavathu, EK | 1 |
| Abdel-Rahman, SM; Sabo, JA | 1 |
| Fothergill, AW; Kirkpatrick, WR; McAtee, RK; Patterson, TF; Rinaldi, MG | 1 |
| Bretagne, S; Curfs, JH; Meis, JF; Verweij, PE; Weemaes, CM | 1 |
| Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B | 1 |
| Kämmerer, R; Klempien, I; Kujath, P; Muhl, E | 1 |
| Girija, R; Hwang, YK; Joo, NH; Tan, L; Tan, P; Tee, GY | 1 |
| Bacigalupo, A; Machetti, M; Mordini, N; Paola, D; Van Lint, MT; Veroni, L; Viscoli, C; Zotti, M | 1 |
| Denning, DW; Griffiths, CE | 1 |
| Caillot, D; Denning, DW; Haas, A; Herbrecht, R; Lode, H; Milpied, N; Ribaud, P; Ruhnke, M; Thiel, E | 1 |
| Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ | 1 |
| De Vries-Hospers, HG; Meis, JF; Rijs, AJ; Te Dorsthorst, DT; Verweij, PE | 1 |
105 review(s) available for voriconazole and Aspergillosis
| Article | Year |
|---|---|
Spinal epidural abscess caused by Aspergillus spp masquerading as spinal tuberculosis in a person with HIV.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Epidural Abscess; Female; HIV Infections; HIV-1; Humans; Itraconazole; Tuberculosis; Voriconazole | 2021 |
Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Echinocandins; Endocarditis; Female; Humans; Microbial Sensitivity Tests; Voriconazole | 2022 |
Aspergillus pleural empyema in a chronic smoker - A case report and review of literature.
Topics: Aspergillosis; Aspergillus; Empyema, Pleural; Humans; Male; Smokers; Voriconazole | 2022 |
Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.
Topics: Antifungal Agents; Aspergillosis; Child; Echinocandins; Humans; Invasive Fungal Infections; Voriconazole | 2022 |
Aspergillus spp. osteoarticular infections: an updated systematic review on the diagnosis, treatment and outcomes of 186 confirmed cases.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Microbial Sensitivity Tests; Treatment Outcome; Voriconazole | 2022 |
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
Invasive aspergillosis in liver transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Fungal Infections; Liver Transplantation; Transplant Recipients; Voriconazole | 2023 |
Lethal thrombosis of the iliac artery caused by Aspergillus fumigatus after liver transplantation: case report and review of the literature.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fatal Outcome; Female; Humans; Iliac Artery; Liver Transplantation; Thrombosis; Voriconazole | 2019 |
Orbital aspergillosis: a case report and review of the literature.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Voriconazole | 2021 |
Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases.
Topics: Aspergillosis; Central Nervous System; Female; Humans; Male; Middle Aged; Neuroaspergillosis; Treatment Outcome; Voriconazole | 2021 |
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients.
Topics: Antifungal Agents; Aspergillosis; Hematology; Humans; Invasive Fungal Infections; Voriconazole | 2021 |
Aspergillosis of central nervous system in patients with leukemia and stem cell transplantation: a systematic review of case reports.
Topics: Antifungal Agents; Asia; Aspergillosis; Central Nervous System; Databases, Factual; Europe; Female; Humans; Leukemia; Male; Stem Cell Transplantation; Voriconazole | 2021 |
Invasive mould infections in the ICU setting: complexities and solutions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole | 2017 |
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cryoglobulinemia; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Invasive Fungal Infections; Lipopeptides; Male; Thyroidectomy; Thyroiditis, Suppurative; Thyrotoxicosis; Treatment Outcome; Voriconazole | 2017 |
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature.
Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Intestinal Perforation; Intestine, Small; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Neutropenia; Treatment Outcome; Voriconazole | 2018 |
Voriconazole Autoinduction and Saturable Metabolism After Cessation of Rifampin in a Patient With Invasive Central Nervous System Aspergillus: Importance of Therapeutic Drug Monitoring.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Interactions; Drug Monitoring; Humans; Male; Rifampin; Safety-Based Drug Withdrawals; Voriconazole | 2019 |
Voriconazole as mono-therapy in orbitofrontal erosive aspergillosis without gross total resection: A case report and review of literature.
Topics: Antifungal Agents; Aspergillosis; Biopsy; Humans; Immunocompetence; Male; Middle Aged; Triazoles; Voriconazole | 2018 |
Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Network Meta-Analysis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Orbital apex syndrome secondary to aspergilloma masquerading as a paranasal sinus tumor: A case report and literature review.
Topics: Antifungal Agents; Aspergillosis; Cranial Nerve Diseases; Diagnostic Errors; Eye Infections, Fungal; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Ophthalmoplegia; Orbital Diseases; Paranasal Sinus Neoplasms; Syndrome; Treatment Outcome; Vision Disorders; Voriconazole | 2018 |
Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Triazoles; Voriconazole | 2019 |
A suppurative thyroiditis and perineal subcutaneous abscess related with aspergillus fumigatus: a case report and literature review.
Topics: Abscess; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dermatomycoses; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Lupus Erythematosus, Systemic; Middle Aged; Perineum; Suction; Thyroiditis, Suppurative; Voriconazole | 2018 |
Aspergillus terreus-related ureteral obstruction in a diabetic patient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diabetes Complications; Humans; Lithotripsy; Male; Middle Aged; Pyrimidines; Stents; Tomography, X-Ray Computed; Triazoles; Ureter; Ureteral Obstruction; Voriconazole | 2013 |
Aspergillus vertebral osteomyelitis in immunocompetent subjects: case report and review of the literature.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Diabetes Complications; Humans; Male; Osteomyelitis; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2013 |
Combination antifungal therapy for invasive fungal infections in children and adults.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2013 |
Mold infections in lung transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bronchiolitis Obliterans; Fungi; Humans; Lung Diseases, Fungal; Lung Transplantation; Neoplasms, Squamous Cell; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2013 |
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Resistance, Fungal; Humans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fungal infections and treatment in cystic fibrosis.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole | 2013 |
Pituitary aspergillosis in a kidney transplant recipient and review of the literature.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus; Fatal Outcome; Female; Humans; Hyphae; Immunocompromised Host; Immunosuppressive Agents; Infarction, Anterior Cerebral Artery; Kidney Transplantation; Pituitary Diseases; Pituitary Gland; Spores, Fungal; Voriconazole | 2013 |
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole | 2014 |
[Invasive fungal rhinosinusitis in an apparently immunocompetant patient].
Topics: Aged; Antifungal Agents; Aortic Valve Stenosis; Aspergillosis; Chronic Disease; Female; Humans; Immunocompetence; Incidental Findings; Maxillary Sinusitis; Preoperative Care; Pyrimidines; Recurrence; Rhinitis; Triazoles; Voriconazole | 2013 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
Treatment of refractory Aspergillus otomycosis with voriconazole: case series and review.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Chronic Disease; Female; Humans; Male; Middle Aged; Otomycosis; Voriconazole; Young Adult | 2014 |
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cholesterol; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2014 |
The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Models, Biological; Mutation; Translational Research, Biomedical; Triazoles; Voriconazole | 2014 |
Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity.
Topics: Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Humans; Treatment Failure; Voriconazole | 2014 |
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach.
Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Evidence-Based Practice; Humans; Neoplasms; Voriconazole | 2015 |
[Thalamo-mesencephalic aspergillus abscess in a heart transplant subject: a case report and literature review].
Topics: Administration, Intravenous; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Brain Abscess; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Male; Mesencephalon; Thalamus; Time Factors; Treatment Outcome; Voriconazole | 2015 |
Isavuconazole: A New Option for the Management of Invasive Fungal Infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidemia; Candidiasis; Candidiasis, Invasive; Clinical Trials as Topic; Drug Resistance, Fungal; Humans; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Systemic aspergilloma post aortic root surgery following coronary artery stenting: diagnostic and management dilemma.
Topics: Adult; Antifungal Agents; Aortic Valve; Aortic Valve Stenosis; Aspergillosis; Aspergillus fumigatus; Chest Pain; Echocardiography; Endocarditis; Humans; Male; Treatment Outcome; Vascular Surgical Procedures; Voriconazole | 2015 |
Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review.
Topics: Antifungal Agents; Aspergillosis; Candidemia; Drug Monitoring; Humans; Mycoses; Voriconazole | 2015 |
Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature.
Topics: Adult; Antifungal Agents; Aspergillosis; Debridement; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Male; Scedosporium; Voriconazole | 2016 |
Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Galactose; Humans; Mannans; Proteoglycans; Triazoles; Voriconazole | 2015 |
Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lung Transplantation; Magnetic Resonance Imaging; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Emergence of Azole Resistance in Aspergillus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
Late aspergilloma of a renal allograft without need for operative management: a case report and review of the literature.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Immunocompromised Host; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Voriconazole | 2016 |
Invasive Aspergillosis in Hematological Patients.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Biomarkers; Echinocandins; Hematologic Neoplasms; Humans; Neutropenia; Opportunistic Infections; Risk Factors; Stem Cell Transplantation; Tomography, X-Ray Computed; Voriconazole | 2016 |
Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1→3)-β-D-glucan.
Topics: Antifungal Agents; Aspergillosis; beta-Glucans; Cerebral Ventriculitis; Cerebrospinal Fluid; Drug Monitoring; Germinoma; Humans; Immunologic Factors; Pituitary Neoplasms; Proteoglycans; Treatment Outcome; Voriconazole | 2017 |
Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Humans; Liver Function Tests; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2008 |
Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
Topics: Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Otitis Externa; Pyrimidines; Radiography; Temporal Bone; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Diagnosis and treatment of aspergillosis in children.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2009 |
Aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Echinocandins; Humans; Immunity, Cellular; Immunity, Innate; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2009 |
Unilateral ureteral obstruction caused by Aspergillus, subgenus Nidulantes in a patient on steroid therapy: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Bezoars; Female; Humans; Immunocompromised Host; Middle Aged; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Triazoles; Ureteral Obstruction; Voriconazole | 2010 |
Primary invasive oral aspergillosis: an updated literature review.
Topics: Acyclovir; Aged; Amphotericin B; Antifungal Agents; Antiviral Agents; Aspergillosis; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mouth Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Aspergillus fumigatus joint infection: a review.
Topics: Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Drainage; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Middle Aged; Pyrimidines; Sacroiliac Joint; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Invasive aspergillosis in patients with liver disease.
Topics: Aged; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Liver Diseases; Lung; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2011 |
Anidulafungin: when and how? The clinician's view.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Antifungal prophylaxis in haematology patients: the role of voriconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2012 |
Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Encephalitis; Humans; Liver Transplantation; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole in clinical practice.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Evidence-Based Medicine; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2013 |
Pharmacoeconomic assessment of therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cost-Benefit Analysis; Empirical Research; Humans; Length of Stay; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole: in the treatment of invasive aspergillosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Injections, Intravenous; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole: a new triazole antifungal agent.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Dermatitis; Drug Interactions; Exanthema; Humans; Liver; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Voriconazole - applications and perspectives].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Pyrimidines; Triazoles; Voriconazole | 2002 |
[Aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Biomarkers; Diagnosis, Differential; Echinocandins; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2003 |
Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Humans; Immunocompetence; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pyrimidines; Risk Assessment; Severity of Illness Index; Spondylitis; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole.
Topics: Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Fungi; Half-Life; Humans; Intestinal Absorption; Male; Microbial Sensitivity Tests; Pyrimidines; Randomized Controlled Trials as Topic; Scedosporium; Tissue Distribution; Triazoles; Voriconazole; Yeasts | 2003 |
[New antifungal agents: voriconazole and caspofungin].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Experience with voriconazole in invasive aspergillosis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Aspergillus fumigatus septic arthritis complicating intra-articular corticosteroid injection.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Debridement; Diagnosis, Differential; Humans; Injections, Intra-Articular; Magnetic Resonance Imaging; Male; Pain; Pyrimidines; Shoulder Injuries; Shoulder Joint; Triamcinolone Acetonide; Triazoles; Voriconazole | 2004 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
[Invasive aspergillosis: clinical manifestations and treatment].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole | 2003 |
Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Heart Transplantation; Humans; Male; Mediastinitis; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up.
Topics: Abscess; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Diseases; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides, Cyclic; Prostatic Diseases; Pyrimidines; Retroperitoneal Space; Triazoles; Voriconazole | 2005 |
A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Female; Heart Transplantation; Humans; Lipopeptides; Mediastinitis; Middle Aged; Peptides, Cyclic; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 2005 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Chemoprevention; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Voriconazole-medicalneeds, evidence, potential for the future].
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Candida; Candidiasis; Guinea Pigs; Humans; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Fungal infections in bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole | 2006 |
Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review.
Topics: Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Immunocompetence; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2006 |
[Efficacies and clinical roles of new antifungal agents].
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Zygomycosis after hematogeneic stem cell transplantation--a current problem?].
Topics: Aspergillosis; Cancer Care Facilities; Cross Infection; Cross-Sectional Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Long-Term Care; Opportunistic Infections; Pyrimidines; Risk Factors; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[Voriconazole as an effective therapy against pulmonary aspergillosis in a man with immunodeficiency virus-infection: a case report].
Topics: Antifungal Agents; Aspergillosis; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole | 2007 |
Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fever; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2007 |
Changing epidemiology of rare mould infections: implications for therapy.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis | 2007 |
[The role of voriconazole in the treatment of emerging mycoses].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2007 |
Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Aspergillus fumigatus; HIV Infections; Humans; Kidney Diseases; Male; Pyrimidines; Radiography; Tomography Scanners, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Immunosuppression Therapy; Lipopeptides; Liver Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography, Thoracic; Tomography, Emission-Computed; Triazoles; Voriconazole | 2008 |
35 trial(s) available for voriconazole and Aspergillosis
| Article | Year |
|---|---|
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2023 |
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Drug Monitoring; Humans; Invasive Fungal Infections; Prospective Studies; Retrospective Studies; Voriconazole | 2023 |
Comment on 'Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: A multicentre, prospective, cluster randomised, crossover clinical trial'.
Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Humans; Invasive Fungal Infections; Prospective Studies; Voriconazole | 2023 |
In reply to comment on 'Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicenter, prospective, cluster randomised, crossover clinical trial'.
Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Humans; Invasive Fungal Infections; Prospective Studies; Voriconazole | 2023 |
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Topics: Aspergillosis; Double-Blind Method; Humans; Triazoles; Voriconazole | 2023 |
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2019 |
Steady-state pharmacokinetics of oral voriconazole and its primary metabolite, N-oxide voriconazole, pre- and post-autologous peripheral stem cell transplantation.
Topics: Aged; Antifungal Agents; Aspergillosis; Cyclic N-Oxides; Female; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Triazoles; Voriconazole | 2013 |
Voriconazole prophylaxis in children with cancer: changing outcomes and epidemiology of fungal infections.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mycoses; Treatment Outcome; Voriconazole; Young Adult | 2013 |
Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Monte Carlo Method; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2014 |
Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Asthma; Double-Blind Method; Drug Administration Schedule; Female; Humans; Immunoglobulin E; Intention to Treat Analysis; Male; Middle Aged; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Voriconazole | 2014 |
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Body Weight; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Models, Statistical; Prospective Studies; Voriconazole | 2014 |
Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis.
Topics: Administration, Intravenous; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Treatment Outcome; Voriconazole | 2015 |
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Therapy, Combination; Echinocandins; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Male; Mannans; Middle Aged; Platelet Count; Treatment Outcome; Voriconazole; Young Adult | 2015 |
Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Corneal Ulcer; Double-Blind Method; Drug Resistance, Fungal; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Voriconazole | 2015 |
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Double-Blind Method; Female; Glomerular Filtration Rate; Hospital Charges; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2016 |
Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Invasive; Child; Child, Preschool; Female; Humans; Male; Prospective Studies; Voriconazole | 2017 |
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Fees, Pharmaceutical; Female; Hospitalization; Humans; Male; Models, Econometric; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cystic Fibrosis; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Aspergillus; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Republic of Korea; Risk Factors; Triazoles; Voriconazole; Young Adult | 2011 |
The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.
Topics: Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Chi-Square Distribution; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Single-Blind Method; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Phase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2002 |
Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Child, Preschool; Humans; Middle Aged; Osteitis; Osteomyelitis; Pyrimidines; Salvage Therapy; Spondylitis; Triazoles; Voriconazole | 2005 |
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Itraconazole; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Costs; Humans; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Changes in causes of death over time after treatment for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cause of Death; Graft vs Host Disease; Humans; Neoplasms; Pyrimidines; Survival Rate; Time Factors; Triazoles; Voriconazole | 2008 |
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2002 |
642 other study(ies) available for voriconazole and Aspergillosis
| Article | Year |
|---|---|
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Pyrimidinones; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiophenes; Triazoles | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Clinical Trials as Topic; Female; Health Surveys; Humans; Infant; Male; Middle Aged; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2008 |
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzamidines; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Specific Pathogen-Free Organisms; Treatment Outcome | 2008 |
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2008 |
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Base Sequence; Colony Count, Microbial; Disease Models, Animal; DNA Primers; DNA, Fungal; Galactose; Guinea Pigs; Humans; Immunoenzyme Techniques; Lung; Lung Diseases, Fungal; Male; Mannans; Mycology; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2008 |
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic Fibrosis; Drug Resistance, Fungal; Epithelial Cells; Humans; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Respiratory Tract Infections | 2008 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Administration Schedule; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Triazoles | 2010 |
Voriconazole pharmacokinetics in liver transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Female; Genotype; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2010 |
Broad-spectrum azoles and flucloxacillin: a dangerous match.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Interactions; Drug Therapy, Combination; Female; Floxacillin; Humans; Male; Middle Aged; Nitriles; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Triazoles; Voriconazole | 2022 |
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada.
Topics: Antifungal Agents; Aspergillosis; Canada; Cost-Benefit Analysis; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single-centre study.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2022 |
Molds and More: Rare Fungal Infections in Preterm Infants <24 Weeks of Gestation.
Topics: Antifungal Agents; Aspergillosis; Female; Fungi; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Mycoses; Pregnancy; Voriconazole | 2022 |
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.
Topics: Animals; Antifungal Agents; Aspergillosis; Clinical Decision Rules; Invasive Fungal Infections; Triazoles; Voriconazole | 2021 |
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; COVID-19; Drug Resistance, Fungal; Humans; SARS-CoV-2; Voriconazole | 2021 |
Toxic optic neuropathy due to voriconazole: possible potentiation by reduction of CYP2C19 activity.
Topics: Adolescent; Antifungal Agents; Antitubercular Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Drug Synergism; Ethambutol; Humans; Male; Toxic Optic Neuropathy; Tuberculosis, Pulmonary; Voriconazole | 2021 |
Successful treatment of hepatic and mesh Aspergillosis in a neonate with giant omphalocele.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Child; Hernia, Umbilical; Humans; Infant, Newborn; Invasive Fungal Infections; Male; Surgical Mesh; Voriconazole | 2022 |
Antifungals influence the immune-related transcriptomic landscape of human monocytes after Aspergillus fumigatus infection.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Microbial Sensitivity Tests; Monocytes; Transcriptome; Voriconazole | 2022 |
Voriconazole therapeutic drug monitoring among lung transplant recipients receiving targeted therapy for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Humans; Invasive Fungal Infections; Lung; Retrospective Studies; Transplant Recipients; Voriconazole | 2022 |
[Evaluation dosing intravenous voriconazole three times a day vs twice daily for the treatment of invasive aspergillosis in immunocompromised children: therapeutic drugs monitoring and safety].
Topics: Antifungal Agents; Aspergillosis; Child; Humans; Invasive Fungal Infections; Pharmaceutical Preparations; Voriconazole | 2022 |
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Female; Fluconazole; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole | 2023 |
Interaction of Amiodarone with Azoles Against Aspergillus Planktonic Cells and Biofilms in vitro.
Topics: Amiodarone; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Biofilms; Itraconazole; Microbial Sensitivity Tests; Plankton; Voriconazole | 2022 |
A mould in the fold should never grow old: cutaneous aspergillosis in a preterm neonate.
Topics: Antifungal Agents; Aspergillosis; Fungi; Humans; Infant, Newborn; Voriconazole | 2023 |
Pediatric Invasive Aspergillosis: a Retrospective Review of 59 Cases.
Topics: Antifungal Agents; Aspergillosis; Child; Female; Humans; Invasive Fungal Infections; Male; Retrospective Studies; Voriconazole | 2023 |
Safety of an Intravenous Formulation of Voriconazole as an Intramuscular Injection in Pigeons (
Topics: Animals; Aspergillosis; Columbidae; Injections, Intramuscular; Pectoralis Muscles; Voriconazole | 2022 |
Manifestations, Prevalence, Management and Outcome of Invasive
Topics: Antifungal Agents; Aspergillosis; Cross-Sectional Studies; Humans; Liver Transplantation; Mycoses; Prevalence; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2024 |
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Caspofungin; Drug Resistance, Fungal; Larva; Microbial Sensitivity Tests; Voriconazole | 2022 |
Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Voriconazole | 2023 |
Invasive cerebral aspergillosis in non-neutropenic patients: A case series from Western India.
Topics: Adult; Aspergillosis; Aspergillus; COVID-19; France; Galactose; Humans; Mannans; Voriconazole | 2023 |
Afu-Emi1 Contributes to Stress Adaptation and Voriconazole Susceptibility in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Hydrogen Peroxide; Microbial Sensitivity Tests; Reactive Oxygen Species; Voriconazole | 2023 |
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies.
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Nitriles; Prospective Studies; Triazoles; Voriconazole | 2023 |
Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Calmodulin; Female; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Nystatin; Otomycosis; Voriconazole | 2023 |
Case report: nanopore targeted sequencing in the diagnosis of invasive pulmonary Aspergillus infection in a patient with acute promyelocytic leukemia.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Promyelocytic, Acute; Nanopores; Quality of Life; Voriconazole | 2023 |
Voriconazole-induced psychosis in rhino-orbital invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Male; Psychotic Disorders; Pyrimidines; Voriconazole | 2023 |
Epidemiology and antifungal susceptibilities of clinically isolated
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2023 |
Fatal invasive pulmonary aspergillosis in non-immunocompromised host: A case report.
Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Voriconazole | 2023 |
Topics: Administration, Ophthalmic; Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Eye Infections, Fungal; Female; Humans; Itraconazole; Phacoemulsification; Scleritis; Visual Acuity; Vitrectomy; Voriconazole | 2020 |
Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cohort Studies; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2020 |
Pharmacokinetics of voriconazole after a single intramuscular injection in large falcons (Falco spp.).
Topics: Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Injections, Intramuscular; Male; Voriconazole | 2020 |
[Aspergillus spondylodiscitis in a patient treated with ibrutinib].
Topics: Adenine; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Combined Modality Therapy; Discitis; Humans; Immunosuppressive Agents; Laminectomy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Protein Kinase Inhibitors; Rituximab; Voriconazole | 2020 |
Efficacy of Voriconazole against Aspergillus fumigatus Infection Depends on Host Immune Function.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Immunity, Cellular; Larva; Macrophages; Microbial Sensitivity Tests; Spores, Fungal; Voriconazole; Zebrafish | 2020 |
An Extremely Premature Newborn with Cutaneous Lesions.
Topics: Abruptio Placentae; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cesarean Section; Debridement; Dermatomycoses; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Uterine Hemorrhage; Voriconazole | 2019 |
Therapeutic drug monitoring and safety of voriconazole in elderly patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Inflammation; Infusions, Intravenous; Invasive Fungal Infections; Male; Middle Aged; Procalcitonin; Retrospective Studies; Voriconazole | 2020 |
Oral administration of voriconazole with surgical fungal plaque debridement for the treatment of sinonasal aspergillosis with cribriform plate lysis in three dogs.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Debridement; Dog Diseases; Dogs; Ethmoid Bone; Nose Diseases; Voriconazole | 2020 |
Topics: Administration, Ophthalmic; Administration, Oral; Adult; Aspergillosis; Aspergillus; Ciprofloxacin; Coinfection; Conjunctiva; Corynebacterium; Corynebacterium Infections; Dacryocystorhinostomy; Drug Therapy, Combination; Female; Humans; Intubation; Lacrimal Duct Obstruction; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Prostheses and Implants; Retrospective Studies; Slit Lamp Microscopy; Voriconazole | 2020 |
[Cryptic Aspergillus species - a case report of chronic cavitary pulmonary Aspergillus lentulus infection in a heart transplant recipient].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Heart Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Transplant Recipients; Triazoles; Voriconazole | 2019 |
Diagnosis and management of lumbar
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Discitis; Dog Diseases; Dogs; Fatal Outcome; Female; Magnetic Resonance Imaging; Osteomyelitis; Tomography, X-Ray Computed; Voriconazole | 2019 |
Invasive oral and nasal aspergillosis in an immunocompetent child.
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Humans; Immunocompromised Host; Male; Mouth; Nose; Voriconazole | 2020 |
Invasive Tracheobronchial Aspergillosis with Bronchial Ulcers Complicated by Nontuberculous Mycobacterial Disease.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchial Diseases; Bronchoscopy; Diagnosis, Differential; Humans; Male; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ulcer; Voriconazole | 2020 |
Primary cutaneous
Topics: Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Dermatomycoses; Humans; Immunocompetence; Male; Postoperative Complications; Staining and Labeling; Voriconazole | 2020 |
In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Nitriles; Public Health Surveillance; Pyridines; Triazoles; Voriconazole | 2020 |
Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report.
Topics: Adenine; Aged; Aspergillosis; Aspergillus; Central Nervous System Infections; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung; Magnetic Resonance Imaging; Male; Piperidines; Pyrazoles; Pyrimidines; Voriconazole | 2020 |
Aspergillus meningitis in a patient with chronic lymphocytic leukemia.
Topics: Aged, 80 and over; Antifungal Agents; Antigens, Fungal; Aspergillosis; Diagnosis, Differential; Galactose; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mannans; Meningitis, Fungal; Voriconazole | 2020 |
Aspergillus endophthalmitis: Potential role for vitreous galactomannan testing?
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endophthalmitis; Eye Infections, Fungal; Female; Galactose; Humans; Male; Mannans; Middle Aged; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2020 |
Voriconazole resistance genes in Aspergillus flavus clinical isolates.
Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Aspergillosis; Aspergillus flavus; Biomarkers; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Point Mutation; Sterol 14-Demethylase; Voriconazole | 2020 |
Successful treatment of Aspergillus empyema using combined intrathoracic and intravenous administration of voriconazole: A case report.
Topics: Administration, Intravenous; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chest Tubes; Drug Monitoring; Drug Therapy, Combination; Empyema; Female; Humans; Pleural Effusion; Treatment Outcome; Voriconazole | 2020 |
Improvement of the pharmacokinetic/pharmacodynamic relationship in the treatment of invasive aspergillosis with voriconazole. Reduced drug toxicity through novel rapid release formulations.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Compounding; Drug Liberation; Male; Mannitol; Microbial Sensitivity Tests; Particle Size; Polysorbates; Rats; Rats, Wistar; Surface Properties; Tissue Distribution; Voriconazole | 2020 |
Invasive rhino-orbital-cerebral aspergillosis in an immunocompetent patient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blindness; Central Nervous System Fungal Infections; Diabetes Complications; Eye Infections, Fungal; Humans; Immunocompetence; Invasive Fungal Infections; Male; Middle Aged; Neuroaspergillosis; Orbital Diseases; Rhinitis; Voriconazole | 2020 |
Potential benefit of combination antifungal therapy in
Topics: Abscess; Amphotericin B; Antifungal Agents; Aortic Valve; Aortic Valve Stenosis; Aspergillosis; Aspergillus fumigatus; Azoles; Computed Tomography Angiography; Drug Therapy, Combination; Endocarditis; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Prosthesis-Related Infections; Treatment Outcome; Voriconazole | 2020 |
Allergic Fungal Sinusitis Imitating an Aggressive Skull Base Lesion in the Setting of Pembrolizumab Immunotherapy.
Topics: Abducens Nerve Diseases; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents, Immunological; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Headache; Humans; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Opportunistic Infections; Sinusitis; Skin Neoplasms; Skull Base Neoplasms; Tomography, X-Ray Computed; Voriconazole | 2021 |
Case Report: Beyond the Blood-retina Barrier: Intravitreal Caspofungin for Fungal Endophthalmitis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Blood-Retinal Barrier; Candida; Candidiasis; Caspofungin; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Visual Acuity; Vitrectomy; Voriconazole | 2020 |
Administration of 1% topical voriconazole drops was effective and safe in the treatment of refractory otomycosis without tympanic membrane perforation.
Topics: Administration, Topical; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Audiometry, Pure-Tone; Culture Techniques; Earache; Female; Hearing Loss; Humans; Male; Middle Aged; Otomycosis; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult | 2021 |
A rare infective cause of stroke in an immunocompetent child.
Topics: Anti-Bacterial Agents; Aspergillosis; Aspergillus flavus; Child; Female; Humans; Immunocompetence; Magnetic Resonance Imaging; Stroke; Voriconazole | 2021 |
Angio-invasive Cerebral Aspergillosis Resulting in Hemispheric Infarct in an Immunocompetent Man.
Topics: Adult; Aspergillosis; Aspergillus; Central Nervous System Fungal Infections; Cerebral Infarction; Craniotomy; Debridement; Follow-Up Studies; Humans; Immunocompetence; Male; Voriconazole; Young Adult | 2020 |
Aspergillosis infection over 20 years: a case report of probable vascular invasion in central nervous system.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Brain; Headache; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Probability; Voriconazole | 2020 |
Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage Optimization.
Topics: Antifungal Agents; Aspergillosis; Humans; Retrospective Studies; Serum Albumin; Voriconazole | 2020 |
An Uncommon Cause of Ring-Enhancing Brain Lesion: Cerebral Aspergillosis.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Diseases; Diagnosis, Differential; Humans; Male; Micafungin; Middle Aged; Treatment Outcome; Voriconazole | 2021 |
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.
Topics: Antifungal Agents; Aspergillosis; Clinical Laboratory Techniques; Cost-Benefit Analysis; Diagnosis, Differential; Fungi; Hospitalists; Humans; Mucormycosis; Nitriles; Pyridines; Spain; Standard of Care; Triazoles; Voriconazole | 2021 |
Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
Topics: Amphotericin B; Antifungal Agents; Argentina; Aspergillosis; Aspergillus flavus; Cytochrome P450 Family 51; Drug Resistance, Fungal; Environmental Microbiology; Environmental Monitoring; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2021 |
Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol.
Topics: Aspergillosis; Genotype; Hematologic Diseases; Humans; Multicenter Studies as Topic; Pharmacogenetics; Voriconazole | 2020 |
Haemorrhagic cystitis following the administration of voriconazole in the treatment of central nervous system aspergillosis: a case report.
Topics: Adult; Antifungal Agents; Aspergillosis; Cystitis; Humans; Male; Neoplasm Recurrence, Local; Voriconazole | 2020 |
Congenital bronchial atresia complicated by a lung abscess due to Aspergillus fumigatus: a case report.
Topics: Adult; Aspergillosis; Aspergillus fumigatus; Bronchi; Bronchoscopy; Humans; Lung Abscess; Male; Radiography, Thoracic; Respiratory System Abnormalities; Tomography, X-Ray Computed; Voriconazole | 2021 |
Species distribution and antifungal susceptibility of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Lebanon; Male; Microbial Sensitivity Tests; Middle Aged; Voriconazole; Young Adult | 2021 |
THE ISOLATION AND ANTIMICROBIAL SENSITIVITY OF
Topics: Air Sacs; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Multiple, Fungal; Itraconazole; Lung; Species Specificity; Spheniscidae; Terbinafine; United Kingdom; Voriconazole | 2020 |
Rare Infant Case of Pulmonary Aspergilloma Highlighting Common Challenges With Voriconazole Dosing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Infant; Male; Photosensitivity Disorders; Voriconazole | 2021 |
Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus ochraceus; Biomarkers; Brain Abscess; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Nucleic Acid Testing; Fatal Outcome; Galactose; Humans; Immunocompetence; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Mannans; SARS-CoV-2; Voriconazole | 2021 |
Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
Topics: Antifungal Agents; Aspergillosis; Extracorporeal Membrane Oxygenation; Humans; Invasive Pulmonary Aspergillosis; Voriconazole | 2022 |
Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Otomycosis; Voriconazole | 2022 |
Late outcome after surgical and topical treatment for Aspergillus mediastinitis after heart transplantation.
Topics: Aged; Aspergillosis; Aspergillus; Heart Transplantation; Humans; Male; Mediastinitis; Surgical Wound Infection; Treatment Outcome; Voriconazole | 2021 |
Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Female; Male; Triazoles; Voriconazole | 2021 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
Correlation of serum galactomannan antigen with diagnosis and response to voriconazole in orbital/sino-orbital invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Galactose; Humans; Mannans; Voriconazole | 2021 |
Successful, Combined Long-term Treatment of Cerebral Candidiasis and Aspergillosis in a Liver Transplant Recipient: A Case Report.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Humans; Liver Transplantation; Voriconazole | 2021 |
Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Triazoles; Voriconazole | 2017 |
New pharmacological opportunities for the treatment of invasive mould diseases.
Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cohort Studies; Drug Monitoring; Female; Humans; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Suspensions; Transplant Recipients; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2017 |
Advanced surgical technique for invasive fungal sinusitis: endoscopic orbit-sinus combined approach.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Endoscopy; Ethmoid Sinus; Ethmoid Sinusitis; Female; Humans; Invasive Fungal Infections; Male; Maxillary Sinus; Maxillary Sinusitis; Middle Aged; Nasal Cavity; Orbit; Voriconazole | 2017 |
Claviform aspergillus-related vegetation in the left ventricle of a patient with systemic lupus erythematosus.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Echocardiography; Female; Heart Diseases; Heart Ventricles; Humans; Lupus Erythematosus, Systemic; Voriconazole | 2018 |
Evidence of unique genetic diversity in Aspergillus fumigatus isolates from Cameroon.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cameroon; Genetic Variation; Genotype; Geography; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Phylogeny; Soil Microbiology; Triazoles; Voriconazole | 2017 |
Severe neurological disorders and refractory aspergillosis in an adolescent treated by vincristine and voriconazole.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents, Phytogenic; Aspergillosis; Female; Humans; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vincristine; Voriconazole | 2018 |
Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chickens; Cymenes; Eugenol; Microbial Sensitivity Tests; Monoterpenes; Poultry Diseases; Real-Time Polymerase Chain Reaction; Spores, Fungal; Thymol; Triazoles; Voriconazole | 2017 |
Voriconazole-induced periostitis deformans: serial imaging in a patient with ANCA vasculitis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclophosphamide; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Intestinal Perforation; Male; Methylprednisolone; Middle Aged; Periostitis; Plasmapheresis; Pneumonia; Voriconazole | 2018 |
Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brazil; Drug Resistance, Fungal; Humans; Invasive Fungal Infections; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2017 |
[Histoplasma capsulatum bone and joint infection].
Topics: Aged; Antibodies, Monoclonal, Humanized; Antifungal Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Aspergillosis; Cervical Vertebrae; Coinfection; Female; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Itraconazole; Knee Joint; Osteitis; Spinal Cord Compression; Voriconazole | 2017 |
Rapidly progressive Aspergillus meningitis successfully treated with voriconazole and corticosteroids.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Brain; Female; Humans; Meningitis, Fungal; Tomography Scanners, X-Ray Computed; Voriconazole; Young Adult | 2018 |
[A case of pulmonary alternariosis complicated with aspergillosis].
Topics: Alternariosis; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Humans; Lung Diseases, Fungal; Middle Aged; Treatment Outcome; Voriconazole | 2017 |
A rare complication of chronic granulomatous disease in a child: constrictive aspergillus pericarditis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchopneumonia; Child, Preschool; Echocardiography; Echocardiography, Doppler, Pulsed; Female; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Pericarditis, Constrictive; Pericardium; Radiography, Thoracic; Recombinant Proteins; Tomography, X-Ray Computed; Voriconazole | 2017 |
Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear; Genotype; Hospitals, University; Humans; Itraconazole; Lepidoptera; Microsatellite Repeats; Respiratory System; Triazoles; Voriconazole | 2017 |
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Evolution of Practice Patterns for the Treatment of Fungal Keratitis.
Topics: Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Fusariosis; Health Care Surveys; Humans; Natamycin; Practice Patterns, Physicians'; Surveys and Questionnaires; Voriconazole | 2017 |
Long-Term Favorable Course of Aspergillus Endo-, Myo-, and Pericarditis.
Topics: Adult; Antifungal Agents; Aspergillosis; Heart Diseases; Humans; Male; Voriconazole | 2017 |
Preexisting Cerebral Aspergillosis Successfully Treated After Liver Transplantation: A Case Report.
Topics: Antifungal Agents; Aspergillosis; Humans; Liver Transplantation; Male; Middle Aged; Voriconazole | 2017 |
Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Humans; Infectious Disease Medicine; Microbial Sensitivity Tests; United States; Voriconazole | 2018 |
Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Brain; Humans; Leukemia, Large Granular Lymphocytic; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed; Voriconazole | 2017 |
The challenges of treating aspergillus abdominal aneurysm after hematopoietic cell transplant: Rapid voriconazole metabolizer.
Topics: Aneurysm, Infected; Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Triazoles; Voriconazole | 2019 |
Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cytochrome P-450 CYP2C19; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Female; Genotype; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pantoprazole; Pharmacogenomic Variants; Phenotype; Proton Pump Inhibitors; Risk Assessment; Voriconazole | 2018 |
[In vitro susceptibility of Cuban Aspergillus spp. strains of clinical and environmental origin].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cuba; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Environmental Microbiology; Hospitals; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2017 |
Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Reproducibility of Results; Triazoles; Voriconazole | 2018 |
Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cornea; Disease Models, Animal; Drug Combinations; Drug Synergism; Epithelial Cells; Eye Infections, Fungal; Female; Gene Expression Regulation; Interferons; Interleukins; Keratitis; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Severity of Illness Index; Tacrolimus; Voriconazole; Zymosan | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Aspergilloma.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Lung Diseases, Fungal; Male; Sputum; Tomography, X-Ray Computed; Voriconazole | 2018 |
Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchi; Bronchoalveolar Lavage Fluid; Female; Hepatitis; Humans; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Trachea; Treatment Outcome; Voriconazole | 2018 |
In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2018 |
Isolated Acute Appendicitis Caused by Aspergillus in a Patient Who Underwent Lung Transplantation: A Case Report.
Topics: Appendectomy; Appendicitis; Aspergillosis; Female; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Transplantation; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole | 2018 |
Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole.
Topics: Administration, Topical; Antifungal Agents; Aspergillosis; Aspergillus niger; Cerumen; Female; Humans; Middle Aged; Nystatin; Otomycosis; Prospective Studies; Treatment Outcome; Voriconazole | 2018 |
An unexpected diagnosis in a patient with 2 left atrial pathological masses found by echocardiography.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Echocardiography; Endocarditis; Fatal Outcome; Female; Heart Atria; Humans; Micafungin; Middle Aged; Myxoma; Voriconazole | 2018 |
Prospective survey of azole drug resistance among environmental and clinical isolates of Aspergillus fumigatus in a French University hospital during major demolition works.
Topics: Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cross Infection; Drug Resistance, Fungal; Facility Design and Construction; France; Hospitals, University; Humans; Itraconazole; Voriconazole | 2018 |
Aspergillus terreus Spondylodiscitis in an Immunocompromised Child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Child; Delayed-Action Preparations; Discitis; Drug Monitoring; Humans; Immunocompromised Host; Male; Microbiological Techniques; Voriconazole | 2019 |
CRISPR/Cas9 Genome Editing To Demonstrate the Contribution of Cyp51A Gly138Ser to Azole Resistance in Aspergillus fumigatus.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; CRISPR-Cas Systems; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Editing; Humans; Male; Voriconazole | 2018 |
Is It Time for Systematic Voriconazole Pharmacogenomic Investigation for Central Nervous System Aspergillosis?
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Central Nervous System; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Mutation; Pharmacogenetics; Voriconazole | 2018 |
What is an appropriate dose of voriconazole for the treatment of aspergillosis in African grey parrots (
Topics: Animals; Aspergillosis; Bird Diseases; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Parrots; Voriconazole | 2018 |
Aspergillus endocarditis: Diagnostic criteria and predictors of outcome, A retrospective cohort study.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cross Infection; Drug Therapy, Combination; Endocarditis; Endocarditis, Bacterial; Endocardium; Female; Heart Valve Prosthesis; Hospital Mortality; Humans; Incidence; Male; Middle Aged; Prognosis; Prosthesis-Related Infections; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Voriconazole | 2018 |
[Contiguous cutaneous inflammation secondary to an aspergillus sinusitis].
Topics: Aged; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Erythema; Facial Dermatoses; Humans; Inflammation; Lymphoma; Male; Maxillary Sinusitis; Sarcoidosis; Skin Diseases, Infectious; Voriconazole | 2018 |
Diagnosis and Treatment of Invasive Aspergillus fumigatus Wound Infection Following Subtotal Colectomy for Perforated Toxic Megacolon in an Immunosuppressed Patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colectomy; Debridement; Female; Humans; Immunocompromised Host; Megacolon, Toxic; Postoperative Complications; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Fungal osteomyelitis in a patient with chronic granulomatous disease: Case report and review of the literature.
Topics: Antifungal Agents; Aspergillosis; Aspergillus nidulans; Biopsy; Child; Granulomatous Disease, Chronic; Humans; Lung; Lung Diseases; Male; Osteomyelitis; Ribs; Thoracic Surgery, Video-Assisted; Treatment Outcome; Voriconazole | 2018 |
Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Moths; Terbinafine; Voriconazole | 2018 |
Central Scotoma After Liver Transplant.
Topics: Antifungal Agents; Aspergillosis; Choroiditis; Eye Infections, Fungal; Humans; Liver Transplantation; Male; Middle Aged; Scotoma; Vitreous Body; Voriconazole | 2019 |
Isavuconazole: Case Report and Pharmacokinetic Considerations.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bronchoalveolar Lavage Fluid; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Half-Life; Humans; Immunocompromised Host; Nitriles; Pyridines; Tandem Mass Spectrometry; Triazoles; Voriconazole; Young Adult | 2018 |
Aspergillus pseudodeflectus: a new human pathogen in liver transplant patients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Liver; Liver Transplantation; Microbial Sensitivity Tests; Middle Aged; Transplant Recipients; Voriconazole | 2018 |
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Empiricism; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Precision Medicine; Prognosis; Retrospective Studies; Standard of Care; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2018 |
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchopulmonary Sequestration; Extracorporeal Membrane Oxygenation; Humans; Influenza, Human; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole | 2019 |
An unusual case of cardiac aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Echocardiography; Fatal Outcome; Female; Galactose; Heart; Humans; Mannans; Middle Aged; Tomography, X-Ray Computed; Ventricular Outflow Obstruction; Voriconazole | 2019 |
The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib.
Topics: Adenine; Aged; Antifungal Agents; Aspergillosis; Cerebrum; Humans; Male; Piperidines; Pyrazoles; Pyrimidines; Voriconazole | 2019 |
High-Resolution Melting Assay for Genotyping Variants of the CYP2C19 Enzyme and Predicting Voriconazole Effectiveness.
Topics: Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Genotype; Pharmacokinetics; Polymerase Chain Reaction; Voriconazole | 2019 |
Invasive fungal consecutive infections in a patient with acute myeloid leukaemia.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Female; Fever; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Mucormycosis; Neutropenia; Treatment Outcome; Voriconazole | 2019 |
Case of ultraviolet B-mediated photosensitivity during the administration of voriconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Keratosis, Actinic; Male; Paranasal Sinus Diseases; Photosensitivity Disorders; Skin; Skin Tests; Ultraviolet Rays; Voriconazole | 2019 |
Invasive Thyroid Gland Aspergillosis in a Patient with Systemic Lupus Erythematosus.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Brain; Cerebral Hemorrhage; Female; Galactose; Humans; Lupus Erythematosus, Systemic; Lymph Nodes; Mannans; Thyroid Gland; Tomography, X-Ray Computed; Voriconazole | 2018 |
Pharmacokinetic/Pharmacodynamic Analysis of Voriconazole Against Candida spp. and Aspergillus spp. in Allogeneic Stem Cell Transplant Recipients.
Topics: Administration, Oral; Adult; Aged; Allografts; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Monte Carlo Method; Stem Cell Transplantation; Voriconazole | 2019 |
Aspergillus terreus spondylodiscitis following an abdominal stab wound: a case report.
Topics: Abdominal Injuries; Accidental Falls; Aged; Antifungal Agents; Aspergillosis; Discitis; Epidural Abscess; Fractures, Avulsion; Humans; Laminectomy; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Osteomyelitis; Rib Fractures; Spinal Cord Compression; Spinal Fractures; Thoracic Vertebrae; Voriconazole; Wounds, Stab | 2019 |
Pharmacogenetic testing for the treatment of aspergillosis with voriconazole in two HIV-positive patients.
Topics: Anti-Retroviral Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Drug Dosage Calculations; HIV Seropositivity; Humans; Male; Middle Aged; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Voriconazole | 2019 |
An exacerbation of severe asthma with fungal sensitization successfully treated with voriconazole via a reduction of the fungal burden.
Topics: Aged, 80 and over; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Asthma; Bronchitis; Female; Humans; Immunoglobulin E; Immunoglobulin G; Voriconazole | 2019 |
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Drug Therapy, Combination; Female; Fungal Proteins; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Mutation; Prevalence; Prognosis; Retrospective Studies; Survival Analysis; Voriconazole | 2019 |
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis.
Topics: Administration, Inhalation; Adult; Aerosols; Antifungal Agents; Aspergillosis; Bronchoscopy; Feasibility Studies; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Respiratory Tract Infections; Triazoles; Voriconazole | 2019 |
EUCAST technical note on voriconazole and Aspergillus spp.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Voriconazole induced bradycardia.
Topics: Antifungal Agents; Aspergillosis; Bradycardia; Child; Child, Preschool; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2013 |
Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Heart Transplantation; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole; Young Adult | 2013 |
Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Genes, Fungal; Humans; Kuwait; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole | 2013 |
Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis; Cheilitis; Child; Child, Preschool; Dermatitis, Photoallergic; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Male; Methotrexate; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Echinocandins; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Exacerbation of myasthenia gravis with voriconazole.
Topics: Antifungal Agents; Aspergillosis; Blepharoptosis; Computer Simulation; Disease Progression; Female; Humans; Middle Aged; Myasthenia Gravis; Ophthalmoplegia; Pyrimidines; Triazoles; Voriconazole | 2013 |
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
Topics: Aged; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Resistance, Fungal; Female; Genes, Fungal; Genotype; Hospitals; Humans; Male; Middle Aged; Molecular Typing; Mycological Typing Techniques; Netherlands; Pyrimidines; Residence Characteristics; Selection, Genetic; Sequence Analysis, DNA; Surveys and Questionnaires; Treatment Failure; Triazoles; Voriconazole; Young Adult | 2013 |
Voriconazole resistance in Aspergillus fumigatus: should we be concerned?
Topics: Air Microbiology; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Humans; Male; Molecular Typing; Pyrimidines; Residence Characteristics; Triazoles; Voriconazole | 2013 |
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Topics: Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Germany; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Prevalence; Pyrimidines; Triazoles; Voriconazole | 2013 |
Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Reference Values; Triazoles; Voriconazole | 2013 |
Successful treatment of acute thyroiditis due to Aspergillus spp. in the context of disseminated invasive aspergillosis in a kidney transplant patient.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Female; Humans; Kidney Transplantation; Middle Aged; Postoperative Complications; Pyrimidines; Remission Induction; Thyroiditis; Triazoles; Voriconazole | 2013 |
Aspergillosis sinusitis with cranio-orbital spread in an apparently immunocompetent patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blindness; Brain; Combined Modality Therapy; Debridement; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Ophthalmoplegia; Orbit; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2013 |
Acute chiasmal abscess resulting from perineural extension of invasive sino-orbital aspergillosis in an immunocompetent patient.
Topics: Abscess; Antifungal Agents; Aspergillosis; Cranial Sinuses; Debridement; Humans; Immunocompetence; Immunohistochemistry; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Optic Chiasm; Optic Nerve; Orbital Diseases; Pyrimidines; Triazoles; Visual Fields; Voriconazole | 2014 |
Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus niger; Belgium; Female; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Ulcerative tracheobronchitis due to Aspergillus.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Asthma; Biopsy; Bronchitis; Bronchoscopy; Critical Care; Humans; Incidental Findings; Male; Pyrimidines; Respiration, Artificial; Respiratory Mucosa; Tracheitis; Tracheostomy; Treatment Failure; Treatment Outcome; Triazoles; Ulcer; Voriconazole | 2013 |
Aspergillus tubingenesis endophthalmitis after cataract surgery with implantation of preloaded intraocular lens.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Device Removal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Lipopeptides; Male; Micafungin; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2014 |
Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia.
Topics: Abscess; Acyclovir; Alemtuzumab; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nephritis; Prostatitis; Salvage Therapy; Valacyclovir; Valine; Voriconazole | 2013 |
Utilizing hardware culture in a case of atypical keratitis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Contact Lenses, Hydrophilic; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Fungal; Humans; Male; Mycological Typing Techniques; Natamycin; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2014 |
Chronic granulomatous invasive fungal sinusitis: an evolving approach to management.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Granuloma; Humans; Male; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2014 |
Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Monitoring; Humans; Maximum Tolerated Dose; Mice; Microbial Sensitivity Tests; Models, Statistical; Voriconazole | 2014 |
Aspergillus spondylodiscitis in an immunocompetent patient following spinal anesthesia.
Topics: Adult; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cesarean Section; Debridement; Discitis; Female; Humans; Immunocompetence; Pregnancy; Puerperal Infection; Pyrimidines; Triazoles; Voriconazole | 2014 |
Primary renal aspergillosis and xanthogranulomatous pyelonephritis in an immuno-competent toddler.
Topics: Antifungal Agents; Aspergillosis; Bezoars; Child, Preschool; Humans; Male; Nephrectomy; Nephrostomy, Percutaneous; Pyelonephritis, Xanthogranulomatous; Treatment Outcome; Ureteral Obstruction; Voriconazole | 2014 |
A single aspergillus fumigatus intracranial abscess in an immunocompetent patient with parietal lobe tumorectomy.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Brain Neoplasms; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Parietal Lobe; Postoperative Complications; Prognosis; Voriconazole | 2014 |
Population pharmacokinetic-pharmacodynamic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Chemical and Drug Induced Liver Injury; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Hallucinations; Humans; Male; Middle Aged; Models, Statistical; Photophobia; Prospective Studies; Voriconazole | 2014 |
Posaconazole responsive cerebral aspergillosis in an immunocompetent adult.
Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Encephalitis; Humans; Magnetic Resonance Imaging; Male; Suction; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Brazil; Calmodulin; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Prevalence; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2014 |
Voriconazole toxicity masquerading as septic shock.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Shock, Septic; Voriconazole | 2015 |
Aspergillus mediastinitis presenting as superior mediastinal syndrome in an immunocompetent child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Child; Cytological Techniques; Humans; Male; Mediastinitis; Microbiological Techniques; Treatment Outcome; Voriconazole | 2015 |
Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Voriconazole | 2015 |
Post-laser in situ keratomileusis interface fungal keratitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Postoperative Complications; Retrospective Studies; Surgical Flaps; Voriconazole; Young Adult | 2014 |
Drug interactions between voriconazole, darunavir/ritonavir and tenofovir/emtricitabine in an HIV-infected patient treated for Aspergillus candidus lung abscess.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Aspergillosis; Aspergillus; Darunavir; Drug Interactions; Emtricitabine; HIV Infections; HIV Protease Inhibitors; Humans; Lung Abscess; Male; Ritonavir; Tenofovir; Treatment Outcome; Voriconazole | 2015 |
In vitro combination of voriconazole and miltefosine against clinically relevant molds.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fusariosis; Fusarium; Microbial Sensitivity Tests; Phosphorylcholine; Scedosporium; Voriconazole | 2014 |
Aspergilloma caused by Aspergillus versicolor.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Lung Diseases, Fungal; Voriconazole | 2014 |
Inflammation is associated with voriconazole trough concentrations.
Topics: Adult; Age Factors; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; C-Reactive Protein; Drug Monitoring; Female; Humans; Inflammation; Linear Models; Male; Middle Aged; Retrospective Studies; Sex Factors; Voriconazole | 2014 |
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Costs and Cost Analysis; Germany; Hematologic Diseases; Spain; Voriconazole | 2014 |
Bulky mediastinal aspergillosis mimicking cancer in an immunocompetent patient.
Topics: Adult; Aspergillosis; Aspergillus flavus; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Mediastinal Diseases; Tomography, X-Ray Computed; Voriconazole | 2014 |
Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases.
Topics: Adult; Amphotericin B; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Liver Failure; Liver Transplantation; Male; Middle Aged; Probability; Proportional Hazards Models; Renal Insufficiency; Transplant Recipients; Treatment Outcome; Voriconazole | 2015 |
Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
Topics: Antifungal Agents; Aspergillosis; Australia; Bronchitis; Carcinoma, Squamous Cell; Female; Humans; Keratosis, Actinic; Lung Transplantation; Middle Aged; Skin Neoplasms; Tracheitis; Transplant Recipients; Voriconazole | 2014 |
Aspergillus terreus infection in a sutureless self-sealing incision made during cataract surgery.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Cataract Extraction; Cornea; Female; Humans; Keratitis; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2015 |
Invasive aspergillosis in an allogeneic hematopoietic cell transplant patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Female; Hematopoietic Stem Cell Transplantation; Humans; Oncology Nursing; Practice Guidelines as Topic; Transplantation, Homologous; Treatment Outcome; Voriconazole | 2011 |
Clinical usefulness of therapeutic drug monitoring of voriconazole in a university hospital.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Voriconazole; Young Adult | 2015 |
Invasive aspergillosis presenting as swelling of the buccal mucosa in an immunocompetent individual.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Biopsy; Combined Modality Therapy; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Female; Granuloma; Humans; Mouth Mucosa; Voriconazole | 2015 |
Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model--authors' response.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Voriconazole | 2015 |
Treatment for a eumycetoma infection caused by Aspergillus in an immunocompromised host: a case report.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycetoma; United States; Voriconazole | 2015 |
Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2015 |
Celebrating the ACP centennial: from the annals archive.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Voriconazole | 2015 |
Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cross-Sectional Studies; Humans; Lung Transplantation; Pre-Exposure Prophylaxis; Surveys and Questionnaires; United States; Voriconazole | 2015 |
Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels.
Topics: Adult; Antifungal Agents; Aspergillosis; Cytochrome P-450 Enzyme System; Diarrhea; Drug Interactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Individuality; Male; Middle Aged; Polymorphism, Genetic; Proton Pump Inhibitors; Voriconazole | 2015 |
Adrenal and hepatic aspergillosis in an immunocompetent patient.
Topics: Adrenal Gland Diseases; Adrenal Glands; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Humans; Immunocompetence; Liver; Liver Diseases; Male; Radiography; Voriconazole | 2015 |
Secondary metabolite profiles and antifungal drug susceptibility of Aspergillus fumigatus and closely related species, Aspergillus lentulus, Aspergillus udagawae, and Aspergillus viridinutans.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Gliotoxin; Humans; Itraconazole; Microbial Sensitivity Tests; Virulence Factors; Voriconazole | 2015 |
Septic arthritis of the temporomandibular joint caused by Aspergillus flavus infection as a complication of otitis externa.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus flavus; Debridement; Humans; Male; Otitis Externa; Temporomandibular Joint; Voriconazole | 2015 |
Voriconazole-associated visual disturbances and hallucinations.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Female; Hallucinations; Humans; Vision Disorders; Voriconazole | 2016 |
Causes of death in a contemporary cohort of patients with invasive aspergillosis.
Topics: Aged; Antifungal Agents; Aspergillosis; Cause of Death; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Voriconazole | 2015 |
Renal aspergillosis in a 6-year-old male with Burkitt's lymphoma.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Burkitt Lymphoma; Child; Humans; Kidney Diseases; Male; Voriconazole | 2015 |
Infectious Disease. How to bolster the antifungal pipeline.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Asthma; Cystic Fibrosis; Drug Design; Drug Resistance, Fungal; Humans; Pulmonary Disease, Chronic Obstructive; Voriconazole | 2015 |
In vitro activity of calcium sulfate and hydroxyapatite antifungal disks loaded with amphotericin B or voriconazole in consideration for adjunctive osteomyelitis management.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Calcium Sulfate; Cells, Cultured; Delayed-Action Preparations; Dental Materials; Humans; Hydroxyapatites; Microbial Sensitivity Tests; Osteoblasts; Osteomyelitis; Voriconazole | 2015 |
Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Australia; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Retrospective Studies; Triazoles; Voriconazole | 2015 |
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
Topics: Adult; Amphotericin B; Amputation, Surgical; Antifungal Agents; Aspergillosis; Blast Injuries; Burns; Critical Illness; Debridement; Drug Monitoring; Fusariosis; Humans; Male; Mucormycosis; Mycoses; Voriconazole; War-Related Injuries; Wounds, Penetrating | 2015 |
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cost Savings; Decision Trees; Deoxycholic Acid; Drug Combinations; Echinocandins; Febrile Neutropenia; Galactose; Health Care Costs; Health Resources; Humans; Immunocompromised Host; Lipopeptides; Mannans; Survival Rate; Voriconazole | 2015 |
Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Azoles; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Drug Therapy, Combination; Half-Life; Humans; Microbial Sensitivity Tests; Models, Statistical; Monte Carlo Method; Polyenes; Voriconazole | 2015 |
Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Crosses, Genetic; Drug Resistance, Multiple, Fungal; Fungal Proteins; Genes, Mating Type, Fungal; Genetic Loci; Hydroxymethylglutaryl CoA Reductases; Itraconazole; Larva; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mixed Function Oxygenases; Moths; Mutation; Sterol 14-Demethylase; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.
Topics: Administration, Intravenous; Adult; Aged; Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Humans; Male; Middle Aged; Saliva; Voriconazole | 2015 |
First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France.
Topics: Anti-Bacterial Agents; Antibodies, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Europe; France; Fungal Proteins; Humans; Immunoglobulin E; Itraconazole; Male; Mutation; Retrospective Studies; Voriconazole; Young Adult | 2015 |
Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Thailand; Voriconazole; Young Adult | 2015 |
Brain Abscesses Due to Aspergillus nidulans Infection During Induction Chemotherapy for Acute Lymphoblastic Leukemia.
Topics: Antifungal Agents; Aspergillosis; Aspergillus nidulans; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Humans; Induction Chemotherapy; Lipopeptides; Lung Diseases, Fungal; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Voriconazole | 2015 |
CYP2C19*17 genetic polymorphism--an uncommon cause of voriconazole treatment failure.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 CYP2C19; Humans; Immunocompromised Host; Inactivation, Metabolic; Male; Middle Aged; Polymorphism, Genetic; Stem Cell Transplantation; Transplantation, Homologous; Treatment Failure; Voriconazole | 2015 |
A case of hypertrophic cranial pachymeningitis associated with invasive Aspergillus mastoiditis.
Topics: Antifungal Agents; Aspergillosis; Cranial Fossa, Middle; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Mastoid; Mastoiditis; Meningitis, Fungal; Middle Aged; Neuroaspergillosis; Voriconazole | 2015 |
[Extended voriconazole theraphy and long term survival of a patient with invasive central aspergillosis causing stroke].
Topics: Aged; Antifungal Agents; Antigens, Fungal; Arterial Occlusive Diseases; Aspergillosis; Biomarkers; Carotid Artery, Internal; Central Nervous System Diseases; Diabetes Complications; Diagnostic Imaging; Female; Galactose; Humans; Infusions, Intravenous; Mannans; Paranasal Sinus Diseases; Stroke; Survival; Time Factors; Voriconazole | 2015 |
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Promoter Regions, Genetic; Triazoles; Turkey; Voriconazole; Young Adult | 2015 |
An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Coinfection; Disease Models, Animal; Drug Resistance, Fungal; Humans; Mice; Microbial Sensitivity Tests; Moths; Real-Time Polymerase Chain Reaction; Voriconazole | 2015 |
Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France.
Topics: Adult; Anti-HIV Agents; Antifungal Agents; Aspergillosis; Aspergillus; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; France; HIV Infections; Humans; Invasive Pulmonary Aspergillosis; Male; Medical Records; Middle Aged; Proportional Hazards Models; Survival Rate; Time Factors; Voriconazole | 2015 |
High metabolic N-oxidation of voriconazole in a patient with refractory aspergillosis and CYP2C19*17/*17 genotype.
Topics: Adult; Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Female; Genotype; Homozygote; Humans; Oxidation-Reduction; Treatment Failure; Voriconazole | 2015 |
Gain-of-function single nucleotide variants of the CYP2C19 gene (CYP2C19*17) can identify subtherapeutic voriconazole concentrations in critically ill patients: a case series.
Topics: Antifungal Agents; Aspergillosis; Critical Illness; Cytochrome P-450 CYP2C19; Genotype; Humans; Phenotype; Polymorphism, Single Nucleotide; Retrospective Studies; Voriconazole | 2015 |
Invasive Primary Colonic Aspergillosis in the Immunocompetent Host without Classical Risk Factors.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Colon; Colonic Diseases; Combined Modality Therapy; Humans; Immunocompetence; Laparotomy; Male; Middle Aged; Radiography; Treatment Outcome; Voriconazole | 2015 |
An in vitro and in vivo study on the synergistic effect and mechanism of itraconazole or voriconazole alone and in combination with tetrandrine against Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Cyclophosphamide; Drug Therapy, Combination; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Mice; Microbial Sensitivity Tests; Voriconazole | 2015 |
A Case Report of Mass-Forming Aspergillus Tracheobronchitis Successfully Treated with Voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Bronchitis; Humans; Male; Remission Induction; Tracheitis; Voriconazole | 2015 |
In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Larva; Lepidoptera; Microbial Sensitivity Tests; Survival Analysis; Triazoles; Voriconazole | 2015 |
Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Prognosis; Retrospective Studies; Risk Factors; Skin Neoplasms; Transplant Recipients; Voriconazole; Young Adult | 2016 |
Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cat Diseases; Cats; Cytochrome P-450 Enzyme System; Dog Diseases; Dogs; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
Phototoxicity, Pseudoporphyria, and Photo-onycholysis Due to Voriconazole in a Pediatric Patient With Leukemia and Invasive Aspergillosis.
Topics: Ankle; Aspergillosis; Blister; Catheter-Related Infections; Cefepime; Cephalosporins; Cheilitis; Child; Cicatrix; Clindamycin; Dermatitis, Phototoxic; Echinocandins; Humans; Hypokalemia; Immunocompromised Host; Levofloxacin; Lipopeptides; Magnesium Deficiency; Male; Micafungin; Onycholysis; Photosensitivity Disorders; Porphyrias; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin; Voriconazole | 2015 |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole | 2016 |
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic Errors; Foot Dermatoses; Humans; Immunohistochemistry; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Radiography; Scedosporium; Subcutaneous Tissue; Sudan; Voriconazole | 2015 |
Aspergillus Mediastinitis after Orthotopic Heart Transplantation: A Case Report.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Debridement; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Mediastinitis; Middle Aged; Reoperation; Surgical Flaps; Surgical Wound Infection; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; End Stage Liver Disease; Female; Health Care Costs; Humans; Kaplan-Meier Estimate; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Renal Replacement Therapy; Retrospective Studies; Risk Factors; Transplant Recipients; Treatment Outcome; Voriconazole; Young Adult | 2016 |
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mycological Typing Techniques; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Voriconazole | 2016 |
Aspergillosis prophylaxis with voriconazole for 90 days in high-risk liver transplant recipients: Right drug and duration?
Topics: Antifungal Agents; Aspergillosis; Humans; Liver Transplantation; Pyrimidines; Voriconazole | 2016 |
Oral administration and younger age decrease plasma concentrations of voriconazole in pediatric patients.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Infant; Infant, Newborn; Japan; Retrospective Studies; Voriconazole | 2016 |
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Coordination Complexes; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Triazoles; Voriconazole | 2016 |
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bacterial Typing Techniques; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Epidemiological Monitoring; Fungal Proteins; Gene Expression; Genotype; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mutation; Promoter Regions, Genetic; Triazoles; Voriconazole | 2016 |
Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Cytomegalovirus Infections; Drug Resistance, Fungal; Fungal Proteins; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Transplant Recipients; Triazoles; United States; Voriconazole | 2016 |
A Comparative Treatment Study of Intravitreal Voriconazole and Liposomal Amphotericin B in an Aspergillus fumigatus Endophthalmitis Model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Guinea Pigs; Intravitreal Injections; Voriconazole | 2015 |
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.
Topics: Albumins; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Culture Media; Echinocandins; Humans; Hyphae; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2015 |
Diagnosis and management of aspergillosis in the Netherlands: a national survey.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Netherlands; Surveys and Questionnaires; Voriconazole | 2016 |
A probable drug-to-drug interaction between voriconazole and haloperidol in a CYP2C19 poor metabolizing patient. [corrected].
Topics: Abscess; Adult; Antifungal Agents; Antipsychotic Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Monitoring; Haloperidol; HIV Infections; Humans; Immunocompromised Host; Kidney Diseases; Male; Voriconazole | 2015 |
Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Retrospective Studies; Voriconazole; Young Adult | 2016 |
Voriconazole and cobicistat-boosted antiretroviral salvage regimen co-administration to treat invasive aspergillosis in an HIV-infected patient.
Topics: Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Cobicistat; Drug Synergism; HIV Infections; Humans; Male; Middle Aged; Treatment Outcome; Voriconazole | 2016 |
Aspergillus spp. invasive external otitis: favourable outcome with a medical approach.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Diabetes Complications; Female; Humans; Male; Middle Aged; Necrosis; Organ Transplantation; Otitis Externa; Retrospective Studies; Treatment Outcome; Voriconazole | 2016 |
Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomimetic Materials; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Sputum; Voriconazole | 2016 |
Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy.
Topics: Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Biomarkers; Child; Child, Preschool; Computer Simulation; Drug Monitoring; Female; Fungal Polysaccharides; Galactose; Humans; Male; Mannans; Microbial Sensitivity Tests; Models, Statistical; Precision Medicine; Voriconazole | 2016 |
Aspergillus mediastinitis after cardiac surgery.
Topics: Adult; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Cardiac Surgical Procedures; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Mediastinitis; Voriconazole | 2016 |
Orbital Apex Syndrome Caused by Invasive Aspergillosis as an Adverse Effect of Systemic Chemotherapy for Metastatic Colorectal Cancer: a Case Report.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Biopsy; Colorectal Neoplasms; Eye Pain; Humans; Immunocompromised Host; Liver Neoplasms; Magnetic Resonance Imaging; Male; Opportunistic Infections; Orbital Diseases; Syndrome; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2016 |
A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspergillosis; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Thailand; Voriconazole; Young Adult | 2016 |
Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations.
Topics: Adult; Antifungal Agents; Aspergillosis; C-Reactive Protein; Female; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Voriconazole | 2016 |
Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Female; France; Fungal Proteins; Germany; Humans; Japan; Microbial Sensitivity Tests; Mutation; Voriconazole | 2016 |
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillus; Child; Ciprofloxacin; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Voriconazole | 2016 |
Invasive aspergillosis presenting as an intracardiac mass in an immunocompetent host.
Topics: Administration, Intravenous; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Echocardiography; Heart Diseases; Humans; Immunocompetence; Male; Respiratory Tract Infections; Treatment Outcome; Voriconazole; Young Adult | 2016 |
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
[Clinical analysis of 16 cases of invasive pulmonary aspergillosis in children].
Topics: Anti-Bacterial Agents; Aspergillosis; Child; Cough; Female; Fever; Galactose; Glucocorticoids; Humans; Male; Mannans; Measles; Neutropenia; Retrospective Studies; Risk Factors; Sputum; Voriconazole | 2016 |
Primary Cutaneous Aspergillosis in a Preterm Infant.
Topics: Antifungal Agents; Aspergillosis; Dermatomycoses; Drug-Related Side Effects and Adverse Reactions; Fatal Outcome; Humans; Infant, Newborn; Infant, Premature; Male; Multiple Organ Failure; Voriconazole | 2016 |
High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Multiple, Fungal; Fungal Proteins; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Humans; Iran; Itraconazole; Mutation; Prevalence; Voriconazole | 2016 |
Spondylodiscitis Due to Aspergillus terreus in an Immunocompetent Host: Case Report and Literature Review.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Caspofungin; Discitis; Echinocandins; Histocytochemistry; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Microbiological Techniques; Microscopy; Spine; Tuberculosis, Pulmonary; Voriconazole; Young Adult | 2016 |
Azole susceptibility in clinical and environmental isolates of Aspergillus fumigatus from eastern Hokkaido, Japan.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Fungal Proteins; Humans; Itraconazole; Japan; Microbial Sensitivity Tests; Mutation; Voriconazole | 2016 |
Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Coinfection; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Middle Aged; Voriconazole | 2016 |
The first case of fungal endophthalmitis caused by Emericella nidulans after cataract surgery.
Topics: Antifungal Agents; Aspergillosis; Aspergillus nidulans; Cataract Extraction; Emericella; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Middle Aged; Postoperative Complications; Voriconazole | 2016 |
Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Voriconazole; Young Adult | 2016 |
[Analysis of voriconazole serum concentrations and safety profile in pediatric oncology patients].
Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Immunocompetence; Injections, Intravenous; Male; Neoplasms; Pharmacovigilance; Reference Values; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; Voriconazole | 2016 |
Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
Topics: Administration, Intravenous; Adolescent; Adult; Antifungal Agents; Aspergillosis; beta-Cyclodextrins; Creatinine; Cytochrome P-450 CYP2C19; Drug Compounding; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Voriconazole; Young Adult | 2016 |
A diagnostic riddle in an immunocompetent adult: Meningioma or intracranial fungal granuloma?
Topics: Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Diagnosis, Differential; Granuloma; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Tomography, X-Ray Computed; Voriconazole; Young Adult | 2016 |
Chronic invasive fungal sinusitis: characterization and shift in management of a rare disease.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Chronic Disease; Endoscopy; Female; Humans; Male; Rare Diseases; Sinusitis; Voriconazole | 2016 |
Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Hospitals, University; Humans; Intensive Care Units; Microbial Sensitivity Tests; Netherlands; Prognosis; Retrospective Studies; Treatment Outcome; Voriconazole | 2016 |
Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: Call for improved diagnosis of fungi in sub-Saharan Africa.
Topics: Adolescent; Adult; Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Otitis Media, Suppurative; Tanzania; Triazoles; Voriconazole; Young Adult | 2016 |
[Topical voriconazole as an effective treatment for fungal keratitis].
Topics: Administration, Topical; Adult; Alternariosis; Antifungal Agents; Aspergillosis; China; Eye Infections, Fungal; Female; Fusariosis; Humans; Keratitis; Male; Treatment Outcome; Voriconazole | 2016 |
Voriconazole-induced hepatotoxicity following the administration of PEG-asparaginase: Case report.
Topics: Antifungal Agents; Antineoplastic Agents; Asparaginase; Aspergillosis; Chemical and Drug Induced Liver Injury; Child; Humans; Male; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole | 2017 |
Development and characterization of the voriconazole loaded lipid-based nanoparticles.
Topics: Antifungal Agents; Aspergillosis; Calorimetry, Differential Scanning; Drug Delivery Systems; Lipids; Nanomedicine; Nanoparticles; Particle Size; Pressure; Reproducibility of Results; Serum Albumin; Solubility; Spectroscopy, Fourier Transform Infrared; Temperature; Voriconazole | 2017 |
Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Azoles; Drug Resistance, Fungal; Female; Mice; Microbial Sensitivity Tests; Voriconazole | 2017 |
Aspergillus flavus Keratitis: Experience of a Tertiary Eye Clinic in Turkey.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Corneal Transplantation; Debridement; Female; Humans; Incidence; Keratitis; Male; Middle Aged; Risk Factors; Tertiary Care Centers; Treatment Outcome; Turkey; Voriconazole; Young Adult | 2017 |
The effect of inflammation on voriconazole trough concentrations in children.
Topics: Adolescent; Adult; Age Factors; Antifungal Agents; Aspergillosis; Biological Variation, Population; C-Reactive Protein; Child, Preschool; Cytochrome P-450 Enzyme System; Drug Monitoring; Female; Humans; Inflammation; Microsomes, Liver; Retrospective Studies; Voriconazole | 2017 |
Invasive Aspergillosis of the Stomach and Co-infection With Candida krusei in a Patient With Terminal Liver Failure: A Case Report.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Coinfection; Echinocandins; End Stage Liver Disease; Gastric Mucosa; Humans; Lipopeptides; Liver Transplantation; Stomach Diseases; Voriconazole | 2016 |
Erg4A and Erg4B Are Required for Conidiation and Azole Resistance via Regulation of Ergosterol Biosynthesis in Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Ergosterol; Gene Deletion; Gene Expression Regulation, Fungal; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Oxidoreductases; Saccharomyces cerevisiae Proteins; Spores, Fungal; Voriconazole | 2017 |
Aspergillus Terreus Brain Abscess Complicated by Tension Pneumocephalus in a Patient with Angiosarcoma.
Topics: Aged; Anti-Bacterial Agents; Aspergillosis; Aspergillus; Bacteremia; Brain Abscess; Cefepime; Cephalosporins; Disease Progression; Drug Combinations; Drug Therapy, Combination; Glucocorticoids; Hemangiosarcoma; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pneumocephalus; Proteus mirabilis; Skin Neoplasms; Staphylococcus aureus; Sulfamethizole; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim; Vancomycin; Voriconazole | 2017 |
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Venous-Airway Fistula With Aspergilloma: A Case of an Implanted Catheter Gone Bad.
Topics: Adenocarcinoma; Antifungal Agents; Aspergillosis; Azygos Vein; Bronchial Fistula; Bronchoscopy; Catheters, Indwelling; Female; Humans; Middle Aged; Pancreatic Neoplasms; Silicones; Stents; Tomography Scanners, X-Ray Computed; Treatment Outcome; Voriconazole | 2017 |
Contributions of both ATP-Binding Cassette Transporter and Cyp51A Proteins Are Essential for Azole Resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; ATP Binding Cassette Transporter, Subfamily G, Member 1; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Deletion; Microbial Sensitivity Tests; Promoter Regions, Genetic; Voriconazole | 2017 |
[A suspected case of voriconazole-induced lung injury].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Lung Diseases; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Osteomyelitis of the rib caused by Aspergillus flavus following cardiac surgery.
Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Humans; Male; Osteomyelitis; Pyrimidines; Ribs; Surgical Wound Infection; Thoracic Surgery; Triazoles; Voriconazole | 2009 |
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drosophila melanogaster; Drosophila Proteins; Pyrimidines; Survival Analysis; Toll-Like Receptors; Triazoles; Virulence; Voriconazole | 2008 |
Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Belgium; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Immunocompromised Host; Male; Middle Aged; Models, Economic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2008 |
Angio-oedema as an unusual tolerable side effect of voriconazole therapy.
Topics: Adult; Angioedema; Antifungal Agents; Aspergillosis; Female; Histamine H1 Antagonists; Humans; Infusions, Intravenous; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Designing voriconazole treatment for racing pigeons: balancing between hepatic enzyme auto induction and toxicity.
Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Chromatography, High Pressure Liquid; Columbidae; Female; Injections, Intravenous; Liver; Lung; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2009 |
First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Drug Resistance, Fungal; Fanconi Anemia; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Fungal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2008 |
Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
Topics: Amino Acid Sequence; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pyrimidines; Triazoles; Voriconazole | 2008 |
Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Everolimus; Fatal Outcome; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2008 |
[Chronic necrotizing aspergillosis].
Topics: Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; Chronic Disease; Cough; Female; Fever; Humans; Lung Diseases, Fungal; Middle Aged; Necrosis; Pyrimidines; Triazoles; Voriconazole | 2008 |
Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Debridement; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Soft Tissue Infections; Terbinafine; Triazoles; Voriconazole | 2008 |
Pulmonary aspergillosis in hematologic malignancies: lights and shadows.
Topics: Antifungal Agents; Aspergillosis; Hematologic Neoplasms; Humans; Lung Diseases; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2008 |
Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Drug Therapy; Female; Health Care Costs; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2008 |
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Drug Therapy, Combination; Earache; Humans; Immunocompetence; Male; Mastoid; Mastoiditis; Miconazole; Postoperative Care; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Tympanic Membrane Perforation; Voriconazole | 2009 |
Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Drug Monitoring; Extracorporeal Membrane Oxygenation; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease].
Topics: Adult; Aged; Aged, 80 and over; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Respiratory Tract Diseases; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Case of orbital apex syndrome caused by invasive aspergillosis successfully treated during the diagnostic procedure by the use of voriconazole].
Topics: Aged; Antifungal Agents; Aspergillosis; Female; Humans; Ocular Motility Disorders; Orbital Diseases; Pyrimidines; Syndrome; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2008 |
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole | 2009 |
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
Cerebral aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Brain Abscess; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mood Disorders; Myelodysplastic Syndromes; Personality; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Female; Humans; Male; Middle Aged; Osteomyelitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2009 |
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cyclophosphamide; Disease Models, Animal; Echinocandins; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Otitis Media; Pyrimidines; Rabbits; Triamcinolone Acetonide; Triazoles; Voriconazole | 2009 |
[Two cases of mycoses associated with hematologic disease].
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Case of pulmonary mycoses associated with malignant lymphoma during chemotherapy].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Immunocompromised Host; Lung Diseases, Fungal; Lymphoma; Male; Middle Aged; Muscle Neoplasms; Prednisolone; Psoas Muscles; Pyrimidines; Treatment Outcome; Triazoles; Vincristine; Voriconazole | 2008 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Aspergillus vertebral osteomyelitis and epidural abscess.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Epidural Abscess; Fatal Outcome; Humans; Infusions, Intravenous; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Spinal Cord Compression; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2009 |
Isolated cerebral aspergilloma in a young immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Edema; Female; Humans; Muscle Weakness; Pyrimidines; Seizures; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Female; Humans; Lipopeptides; Male; Middle Aged; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.
Topics: Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP3A; Drug Interactions; Drug Monitoring; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2009 |
Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Coturnix; Disease Models, Animal; Female; Histocytochemistry; Lung; Male; Microbial Sensitivity Tests; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole | 2010 |
New treatment for invasive fungal sinusitis: three cases of chronic invasive fungal sinusitis treated with surgery and voriconazole.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Columbidae; Invasive Pulmonary Aspergillosis; Liver; Pyrimidines; Triazoles; Voriconazole | 2009 |
Cutaneous aspergillosis in a lung transplant recipient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dermatomycoses; Female; Humans; Lung Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Disease Progression; Drug Resistance, Fungal; Evolution, Molecular; Fungal Proteins; Humans; Itraconazole; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2009 |
Fungal keratitis with intracameral extension following penetrating keratoplasty.
Topics: Administration, Oral; Administration, Topical; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Debridement; Drug Administration Schedule; Graft Rejection; Humans; Injections; Keratitis; Keratoconus; Keratoplasty, Penetrating; Male; Middle Aged; Postoperative Care; Prednisolone; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2009 |
Atypical Aspergillus flavus isolates associated with chronic azole therapy.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Azoles; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2009 |
Central nervous system Aspergillus infection after epidural analgesia: diagnosis, therapeutic challenges, and literature review.
Topics: Adult; Analgesia, Epidural; Antifungal Agents; Aspergillosis; Aspergillus; Central Nervous System Infections; Female; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus; Endophthalmitis; Eye Enucleation; Humans; Liver Cirrhosis; Liver Transplantation; Male; Polymerase Chain Reaction; Pyrimidines; Triazoles; Vancomycin; Voriconazole; Young Adult | 2009 |
Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diagnosis, Differential; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Scedosporium; Skin Diseases; Triazoles; Voriconazole | 2009 |
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
[Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system].
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Cerebral Infarction; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2009 |
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Prospective Studies; Pyrimidines; Registries; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Female; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2010 |
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cervical Vertebrae; Drainage; Echinocandins; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Itraconazole; Lipopeptides; Male; Osteomyelitis; Pyrimidines; Saudi Arabia; Thoracic Vertebrae; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Management of obstructive renal failure caused by bilateral renal aspergilloma in an immunocompetent newborn.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bladder Exstrophy; Humans; Infant, Newborn; Male; Nephrostomy, Percutaneous; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Ureterostomy; Voriconazole | 2010 |
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
[Cerebral aspergilloma in an immunocompetent patient: radiological and histopathological findings].
Topics: Antifungal Agents; Aspergillosis; Brain; Central Nervous System Fungal Infections; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Voriconazole-associated myositis.
Topics: Acute Disease; Adult; Antifungal Agents; Aspergillosis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Myositis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Oral voriconazole for invasive fungal skull base infection.
Topics: Adult; Antifungal Agents; Aspergillosis; Biopsy; Diagnosis, Differential; Exophthalmos; Female; Humans; Magnetic Resonance Imaging; Pyrimidines; Radiography; Skull Base; Triazoles; Voriconazole | 2010 |
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole | 2010 |
Recalcitrant fungal tunnel infection treated with intrastromal injection of voriconazole.
Topics: Administration, Topical; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cataract Extraction; Corneal Stroma; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Injections, Intraocular; Middle Aged; Phacoemulsification; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cell Adhesion; Cell Wall; Disease Models, Animal; Glass; Humans; Hydrogen-Ion Concentration; Mice; Mitogen-Activated Protein Kinase Kinases; Plastics; Pyrimidines; Signal Transduction; Survival Analysis; Temperature; Triazoles; Virulence; Virulence Factors; Voriconazole | 2010 |
[Primary cutaneous aspergillosis in an immunocompetent farmworker].
Topics: Adult; Agricultural Workers' Diseases; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy; Dermatomycoses; Dermis; Facial Dermatoses; Humans; Immunocompetence; Male; Neutrophils; Periodic Acid-Schiff Reaction; Pyrimidines; Triazoles; Voriconazole | 2010 |
A case series of unilateral orbital aspergillosis in three cats and treatment with voriconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Cat Diseases; Cats; Eye Diseases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Increasing the dose of voriconazole compensates for enzyme induction by phenytoin.
Topics: Administration, Oral; Adult; Anticonvulsants; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Humans; Phenytoin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Europe; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 2010 |
Aspergillus endocarditis 2003-2009.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Endocarditis; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Surgical Procedures, Operative; Triazoles; Voriconazole; Young Adult | 2011 |
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Guideline Adherence; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Catheters; Child, Preschool; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Pyrimidines; Thoracic Wall; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Transplantation; Lipopeptides; Pyrimidines; Thyroid Gland; Thyroiditis; Triazoles; Voriconazole | 2011 |
[Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis of Aspergillus fumigatus].
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Delayed-Action Preparations; Endophthalmitis; Eye; Female; Intravitreal Injections; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Random Allocation; Triazoles; Voriconazole | 2010 |
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cystic Fibrosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lung Transplantation; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Human tissue distribution of voriconazole.
Topics: Adult; Aged; Aspergillosis; Autopsy; Brain; Female; Humans; Kidney; Liver; Lung; Male; Middle Aged; Myocardium; Pyrimidines; Spleen; Tissue Distribution; Triazoles; Voriconazole; Young Adult | 2011 |
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antifungal Agents; Aspergillosis; Drug Interactions; Fatal Outcome; Humans; Lansoprazole; Male; Pyrimidines; Tachycardia, Ventricular; Triazoles; Voriconazole | 2011 |
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole | 2011 |
Clinical features and outcomes of four patients with invasive fungal sinusitis.
Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Aspergillus infection of supramid orbital implant and hyperostosis of orbital bone: report of a unique case.
Topics: Adult; Aspergillosis; Aspergillus; Combined Modality Therapy; Device Removal; Follow-Up Studies; Humans; Hyperostosis; Male; Nylons; Orbital Fractures; Orbital Implants; Prosthesis-Related Infections; Pyrimidines; Radiography; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Interaction of oxycodone and voriconazole-a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects.
Topics: Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Female; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole | 2011 |
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.
Topics: Anti-Retroviral Agents; Aspergillosis; Aspergillus; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Male; Nitriles; Pneumonia, Aspiration; Pyridazines; Pyrimidines; Ritonavir; Triazoles; Voriconazole | 2011 |
Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Biofilms; Drug Resistance, Fungal; Fungal Proteins; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Mutation; Pyrimidines; Triazoles; Voriconazole | 2011 |
Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Delayed-Action Preparations; Endophthalmitis; Eye; Humans; Intravitreal Injections; Microspheres; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2011 |
Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Fever; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
A vascular graft infection by aspergillus treated without graft removal.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antifungal Agents; Aortic Aneurysm, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Combined Modality Therapy; Coronary Sinus; Coronary Vessels; Debridement; Drug Therapy, Combination; Fever; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Povidone-Iodine; Prosthesis-Related Infections; Pyrimidines; Replantation; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.
Topics: Administration, Ophthalmic; Adult; Aged; Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Female; Fusariosis; Humans; Injections, Intralesional; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Central Nervous System Fungal Infections; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Scedosporium; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Denmark; Drug Resistance, Fungal; Female; Hospitals; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pyrimidines; Respiratory System; Respiratory Tract Infections; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye Infections, Fungal; Female; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole | 2011 |
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole | 2011 |
Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.
Topics: Adult; Antifungal Agents; Aspergillosis; Dermatomycoses; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Stem Cell Transplantation; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Infant; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Paranasal Sinus Diseases; Pyrimidines; Retrospective Studies; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult | 2011 |
Voriconazole-associated severe hyponatremia.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Humans; Hyponatremia; Male; Middle Aged; Pyrimidines; Serum; Triazoles; Voriconazole | 2012 |
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Pigmented fruiting bodies and birefringent crystals in a surgical wound: A clue to Aspergillus niger infection.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus niger; Crystallization; Debridement; Fruiting Bodies, Fungal; Humans; Male; Opportunistic Infections; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Intravitreal voriconazole for the treatment of Aspergillus chorioretinitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Chorioretinitis; Diagnosis, Differential; Eye Infections, Fungal; Follow-Up Studies; Humans; Intravitreal Injections; Male; Microscopy, Acoustic; Pyrimidines; Triazoles; Visual Acuity; Voriconazole | 2011 |
Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Biguanides; Calcineurin Inhibitors; Corneal Ulcer; Cyclosporine; Disinfectants; Drug Synergism; Eye Infections, Fungal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prospective Studies; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Specimen Banks; DNA, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Phylogeny; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2012 |
An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Codon; Culture Media; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Mycological Typing Techniques; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genetic Complementation Test; Genotype; Humans; Microbial Sensitivity Tests; Organisms, Genetically Modified; Pyrimidines; Real-Time Polymerase Chain Reaction; Sterol Regulatory Element Binding Proteins; Transcription, Genetic; Triazoles; Voriconazole | 2012 |
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
[Pulmonary aspergillosis and HIV infection: about two cases].
Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Radiography; Risk Factors; Triazoles; Voriconazole | 2012 |
Population pharmacokinetics of voriconazole in adults.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Bayes Theorem; Case-Control Studies; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Logistic Models; Male; Middle Aged; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole | 2012 |
[Invasive aspergillosis: new tools for a targeted medical management].
Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Clinical Trials as Topic; Comorbidity; Disease Management; Female; France; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Drug Therapy, Combination; Echinocandins; Humans; Male; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features.
Topics: Aged, 80 and over; Animals; Aspergillosis; Aspergillus; Bronchial Diseases; Bronchoscopy; Diabetes Mellitus; Female; Humans; Hydrogen Peroxide; Immunocompromised Host; Lung; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
Topics: Aged, 80 and over; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus; Cardiac Surgical Procedures; Caspofungin; Coronary Care Units; Disease Outbreaks; Echinocandins; Female; Humans; Incidence; Lipopeptides; Male; Middle Aged; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2012 |
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole | 2012 |
The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.
Topics: Adolescent; Agrobacterium tumefaciens; Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Gene Transfer Techniques; Humans; Lung; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Plasmids; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Longitudinal Studies; Mathematical Computing; Microbial Sensitivity Tests; Models, Statistical; Mutation; Netherlands; Promoter Regions, Genetic; Pyrimidines; Sequence Analysis, DNA; Tandem Repeat Sequences; Triazoles; Voriconazole | 2012 |
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2012 |
Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cause of Death; Child; Child, Preschool; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Voriconazole; Young Adult | 2012 |
High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Pyrimidines; Severity of Illness Index; Triazoles; Voriconazole; Young Adult | 2012 |
Intracameral and topical voriconazole for fungal corneal endoexudates.
Topics: Administration, Topical; Adult; Aged; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Corneal Ulcer; Exudates and Transudates; Eye Infections, Fungal; Humans; Injections, Intraocular; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole; Young Adult | 2012 |
Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hematologic Diseases; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy.
Topics: Antifungal Agents; Aspergillosis; Debridement; Humans; Male; Middle Aged; Negative-Pressure Wound Therapy; Pyrimidines; Sternotomy; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Recurrent fungal iris granuloma in a 10-year-old child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Granuloma; Humans; Iris Diseases; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Colectomy; Emergencies; Enterocolitis, Necrotizing; Female; Humans; Ileostomy; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult | 2012 |
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Aspergillus endocarditis in a native valve without prior cardiac surgery.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Humans; Male; Pyrimidines; Triazoles; Ultrasonography; Voriconazole | 2012 |
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cohort Studies; Demography; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Length of Stay; Lipopeptides; Lung; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Triazoles; Voriconazole | 2013 |
Azole preexposure affects the Aspergillus fumigatus population in patients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Multigene Family; Polymorphism, Single Nucleotide; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Pancreatitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Candidemia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Japan; Male; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Multiple fungal brain abscesses in a child with acute lymphoblastic leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Brain Abscess; Child, Preschool; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2012 |
Clinical images: voriconazole-induced periostitis deformans.
Topics: Antifungal Agents; Aspergillosis; Female; Humans; Middle Aged; Periostitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Chi-Square Distribution; Female; Humans; Incidence; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2012 |
Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Voriconazole | 2012 |
VFEND® (voriconazole)-associated hypoglycaemia without identified drug interaction.
Topics: Antifungal Agents; Aspergillosis; Enterocolitis; Glucose; Humans; Hyperinsulinism; Hypoglycemia; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Syncope; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.
Topics: Adolescent; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Cluster Analysis; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole; Young Adult | 2012 |
Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus niger; Disease Models, Animal; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.
Topics: Adult; Antibodies, Antinuclear; Antifungal Agents; Aspergillosis; Drug Eruptions; Female; Humans; Light; Male; Middle Aged; Patch Tests; Photosensitivity Disorders; Pyrimidines; Sunlight; Triazoles; Voriconazole | 2013 |
Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis.
Topics: Adolescent; Age Factors; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Administration Routes; Drug Administration Schedule; Drug Monitoring; Drug Synergism; Humans; Magnetic Resonance Imaging; Male; Omeprazole; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2012 |
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2012 |
Better hospital nutrition needed to prevent and treat Aspergillus infections.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fever; Fungal Proteins; Germany; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Pyrimidines; Sequence Analysis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole hepatotoxicity in severe liver dysfunction.
Topics: Adult; Aged; Amphotericin B; Analysis of Variance; Antifungal Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Observation; Pyrimidines; Triazoles; Voriconazole | 2013 |
Relapsing cerebral aspergilloma associated with pregnancy.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Fungal Infections; Female; Humans; Infant, Newborn; Magnetic Resonance Imaging; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Seizures; Triazoles; Voriconazole | 2013 |
Pharmacokinetic effect of voriconazole on cyclosporine in the treatment of aspergillosis after renal transplantation.
Topics: Adult; Antiviral Agents; Aspergillosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Czech Republic; Databases, Factual; Echinocandins; Female; Galactose; Humans; Leukemia; Lung Diseases, Fungal; Male; Mannans; Middle Aged; Neutrophils; Pyrimidines; Retrospective Studies; Slovakia; Triazoles; Voriconazole; Young Adult | 2013 |
Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.
Topics: Adolescent; Analysis of Variance; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Echinocandins; Female; Fungal Proteins; Humans; Mice; Mutation; Neutrophils; Promoter Regions, Genetic; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Mice; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Case report of exposure to voriconazole in the second and third trimesters of pregnancy.
Topics: Adult; Aspergillosis; Aspergillus flavus; Female; Humans; Pregnancy; Pregnancy Trimester, Third; Pyrimidines; Triazoles; Voriconazole | 2013 |
Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillosis; Drug Evaluation; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Middle Aged; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Pharmacogenetics and beyond: variability of voriconazole plasma levels in a patient with primary immunodeficiency.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Genetic Association Studies; Granulomatous Disease, Chronic; Humans; Male; Pharmacogenetics; Pyrimidines; Triazoles; Voriconazole | 2012 |
Evaluation of the in vitro activity of voriconazole as predictive of in vivo outcome in a murine Aspergillus fumigatus infection model.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Resistance, Fungal; Galactose; Immunocompromised Host; Kidney; Male; Mannans; Mice; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Galactose; Male; Mannans; Mice; Microbial Sensitivity Tests; Prognosis; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2013 |
Effects of a defective endoplasmic reticulum-associated degradation pathway on the stress response, virulence, and antifungal drug susceptibility of the mold pathogen Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytosol; Drug Resistance, Fungal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endoplasmic Reticulum-Associated Degradation; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Mice; Proteasome Endopeptidase Complex; Protein Folding; Pyrimidines; Survival Analysis; Triazoles; Ubiquitin-Protein Ligases; Virulence; Voriconazole | 2013 |
Selection of the antifungal agent decides prognosis of invasive aspergillosis: case report of a successful outcome with voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Humans; Male; Orbital Diseases; Prognosis; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
Topics: Adolescent; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Body Weight; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Genotype; Humans; Injections, Intravenous; Male; Obesity; Pyrimidines; Triazoles; Voriconazole | 2013 |
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2002 |
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Guinea Pigs; Lipopeptides; Male; Organ Culture Techniques; Peptides; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2002 |
Voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2002 |
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2002 |
An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
The safety of voriconazole.
Topics: Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Liver Function Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Patient Dropouts; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus amphotericin B for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Liposomes; Pyrimidines; Triazoles; Voriconazole | 2002 |
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection.
Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Eye Infections, Fungal; Female; Humans; Orbital Diseases; Pyrimidines; Scleral Buckling; Scleritis; Surgical Wound Infection; Triazoles; Voriconazole | 2003 |
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antigen Presentation; Aspergillosis; Aspergillus fumigatus; Caspofungin; Dendritic Cells; Echinocandins; Lipopeptides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Peptides, Cyclic; Pyrimidines; Specific Pathogen-Free Organisms; T-Lymphocytes; Triazoles; Voriconazole | 2003 |
Voriconazole in the treatment of invasive mold infections in transplant recipients.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
[Update on voriconazole].
Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole | 2003 |
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2003 |
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Spain; Triazoles; Voriconazole | 2003 |
High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Female; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Myeloablative Agonists; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation Conditioning; Triazoles; Voriconazole | 2004 |
Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Sampling Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fungemia; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Polymerase Chain Reaction; Pyrimidines; Sensitivity and Specificity; Serologic Tests; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Leukemia, Myelomonocytic, Acute; Lipopeptides; Male; Middle Aged; Peptides; Peptides, Cyclic; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole | 2003 |
Invasive aspergillosis: current and future challenges in diagnosis and therapy.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Novel effect of voriconazole on conidiation of Aspergillus species.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2004 |
Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Humans; Infusions, Intravenous; Liposomes; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diffusion; Empyema, Pleural; Humans; Male; Pleura; Pyrimidines; Triazoles; Voriconazole | 2004 |
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Prognosis; Prospective Studies; Pyrimidines; Recurrence; Risk; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Dermatomycoses; Female; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole | 2004 |
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Images in cardiovascular medicine. Left ventricular mass after treatment with chemotherapic drugs.
Topics: Acute Disease; Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Echocardiography; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Pyrimidines; Triazoles; Ventricular Outflow Obstruction; Voriconazole | 2004 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Liver Transplantation; Peptides; Peptides, Cyclic; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole.
Topics: Adult; Ambulatory Care; Aspergillosis; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Leg Dermatoses; Long-Term Care; Male; Middle Aged; Outpatients; Pyrimidines; Risk Assessment; Severity of Illness Index; Triazoles; Voriconazole | 2004 |
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Topics: Antifungal Agents; Aspergillosis; Cohort Studies; Female; Graft vs Host Disease; Humans; Logistic Models; Male; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2004 |
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Topics: Adult; Aspergillosis; Aspergillus; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Female; Fungemia; Fungi; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2004 |
Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus.
Topics: Aspergillosis; Aspergillus fumigatus; Brain Abscess; Cerebrospinal Fluid; Female; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Base Sequence; Bronchoalveolar Lavage Fluid; DNA Primers; DNA, Fungal; Humans; Leukemia; Middle Aged; Neoplasms; Polymerase Chain Reaction; Pyrimidines; Transplantation; Triazoles; Voriconazole | 2004 |
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Guinea Pigs; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2004 |
Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Lung Diseases, Fungal; Male; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Combination therapy for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Adverse reactions to voriconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2004 |
Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Postoperative Complications; Pyrimidines; Sirolimus; Triazoles; Voriconazole | 2004 |
Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Heart Transplantation; Humans; Lung Diseases, Fungal; Middle Aged; Myocardial Ischemia; Postoperative Complications; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2004 |
Successful antifungal combination therapy with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2005 |
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost Savings; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Health Care Costs; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole | 2005 |
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Chemoprevention; Humans; Itraconazole; Lung Transplantation; Pyrimidines; Triazoles; Voriconazole | 2005 |
Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Paecilomyces; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2005 |
Economic effects of aspergillosis management in high-risk patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Hospitalization; Humans; Insurance, Health, Reimbursement; Pyrimidines; Triazoles; United States; Voriconazole | 2005 |
Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Male; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Economics, Pharmaceutical; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Improved outcome in central nervous system aspergillosis, using voriconazole treatment.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Child; Child, Preschool; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Child, Preschool; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole; Weil Disease | 2005 |
Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Endocarditis; Heart Valve Prosthesis; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Echinocandins; Guinea Pigs; Kidney; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2005 |
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Markov Chains; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole therapy in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Retrospective Studies; Sputum; Statistics, Nonparametric; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Echinocandins; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Follow-Up Studies; Lipopeptides; Lipoproteins; Micafungin; Ophthalmoscopy; Peptides, Cyclic; Pyrimidines; Rabbits; Retina; Triazoles; Vitreous Body; Voriconazole | 2005 |
Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Brain Abscess; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Liver Failure, Acute; Magnetic Resonance Imaging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2005 |
To treat or not to treat with antifungal agents?
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Sputum; Triazoles; Voriconazole | 2005 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
[Aspergillus bronchitis and aspergilloma treated successfully with voriconazole].
Topics: Antifungal Agents; Aspergillosis; Bronchitis; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Benzamides; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Eruptions; Drug Interactions; Enzyme Inhibitors; Exanthema; Humans; Imatinib Mesylate; Irritants; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Triazoles; Voriconazole | 2005 |
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole | 2005 |
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy.
Topics: Adult; Anticonvulsants; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Breast Neoplasms; Drug Interactions; Humans; Lung Diseases, Fungal; Male; Phenytoin; Pyrimidines; Stevens-Johnson Syndrome; Triazoles; Voriconazole | 2006 |
Voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole | 2005 |
The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
[Invasive multisystemic aspergillosis in an immunocompetent child: case report].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Deoxycholic Acid; Drug Combinations; Fatal Outcome; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.
Topics: Antifungal Agents; Aspergillosis; France; Humans; Immunocompromised Host; Male; Middle Aged; Outcome Assessment, Health Care; Pericardium; Pleura; Pyrimidines; Triazoles; Ultrasonography; Voriconazole | 2006 |
Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Liposomes; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Heart Valve Diseases; Humans; Male; Pulmonary Embolism; Pyrimidines; Sepsis; Triazoles; Tricuspid Valve; Voriconazole | 2006 |
[A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
Topics: Antifungal Agents; Aspergillosis; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Telencephalon; Triazoles; Voriconazole | 2006 |
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillosis; Chi-Square Distribution; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Middle Aged; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole.
Topics: Adult; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Central Nervous System Fungal Infections; Humans; Leukemia, Erythroblastic, Acute; Male; Pyrimidines; Telencephalon; Triazoles; Voriconazole | 2006 |
Nodular erythema as early sign of systemic aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Erythema Nodosum; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Immunosuppressive Agents; Injections; Lung Transplantation; Opportunistic Infections; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole | 2006 |
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Infections; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Kidney; Mice; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Amphotericin B is still the drug of choice for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Pyrimidines; Research Design; Triazoles; Voriconazole | 2006 |
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
A case of pulmonary aspergillosis with lack of response to caspofungin.
Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2006 |
Combination antifungal therapy in solid organ transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Humans; Kidney Transplantation; Liver Transplantation; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2006 |
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Drug Resistance, Fungal; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2006 |
Aspergillus infection limited to renal allograft: case report and review of literature.
Topics: Adult; Aspergillosis; Aspergillus; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole | 2006 |
Disseminated invasive aspergillosis in a patient with acute leukaemia.
Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole | 2006 |
Aspergillus meningitis following spinal anaesthesia for caesarean section in Colombo, Sri Lanka.
Topics: Abducens Nerve Diseases; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Brain; Cesarean Section; Diabetes, Gestational; Fatal Outcome; Female; Fluconazole; Glasgow Coma Scale; Humans; Meningitis, Fungal; Pregnancy; Pyrimidines; Respiration, Artificial; Sri Lanka; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
Topics: Air Sacs; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Hydroxycorticosteroids; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Pyrimidines; Sarcoidosis; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Successful treatment of an Aspergillus fumigatus Infection with voriconazole via a nasogastric tube.
Topics: Administration, Intranasal; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Intubation, Gastrointestinal; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2006 |
Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Aspergillosis; Aspergillus niger; Humans; Immunologic Factors; Male; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Rituximab; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Multi-azole resistance in Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2006 |
Voriconazole prophylaxis in lung transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Female; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Probability; Pyrimidines; Retrospective Studies; Survival Analysis; Time Factors; Triazoles; Voriconazole | 2006 |
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in Intensive Care Unit.
Topics: Antifungal Agents; Aspergillosis; Critical Care; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Models, Economic; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia].
Topics: Aged; Alveolitis, Extrinsic Allergic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Myositis; Opportunistic Infections; Prednisolone; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Invasive sphenoidal aspergillosis: successful treatment with sphenoidotomy and voriconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Endoscopy; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Otorhinolaryngologic Surgical Procedures; Pyrimidines; Severity of Illness Index; Sphenoid Sinus; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology | 2007 |
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus niger; Chronic Disease; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Diseases, Fungal; Lymphatic Irradiation; Necrosis; Pneumonia, Bacterial; Pyrimidines; Radiation Injuries; Radiography; Staphylococcal Infections; Staphylococcus epidermidis; Triazoles; Virginiamycin; Voriconazole | 2006 |
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Body Weight; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Injections, Intravenous; Lipopeptides; Multivariate Analysis; Peptides, Cyclic; Pyrimidines; Severity of Illness Index; Spain; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Torsades de pointes associated with voriconazole use.
Topics: Administration, Oral; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cardiomyopathies; Dermatomycoses; Drug Synergism; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
Voriconazole concentrations in synovial fluid and bone tissues.
Topics: Aged, 80 and over; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Bone and Bones; Chromatography, High Pressure Liquid; Female; Humans; Microbial Sensitivity Tests; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole | 2007 |
Invasive Aspergillus fumigatus associated with liver and bone involvement in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bone Diseases; Humans; Liver Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Chronic invasive sinus aspergillosis in an immunocompetent patient: a case report.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Endoscopy; Humans; Immunocompetence; Male; Paranasal Sinus Diseases; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Multiple-triazole-resistant aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Multiple, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Pyrimidines; Tandem Repeat Sequences; Triazoles; Voriconazole | 2007 |
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Echinocandins; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia.
Topics: Acute Disease; Adult; Aspergillosis; Aspergillus; Humans; Leukemia, Myeloid; Male; Meningitis, Fungal; Pyrimidines; Sarcoma, Myeloid; Thyroid Neoplasms; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful management of Aspergillus liver abscess in a patient with necrotizing fasciitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fasciitis, Necrotizing; Female; Humans; Lipopeptides; Liver Abscess; Peptides, Cyclic; Pregnancy; Pyrimidines; Triazoles; Voriconazole | 2007 |
Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Substance Abuse, Intravenous; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2007 |
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Decision Trees; Drug Combinations; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Models, Economic; Models, Statistical; Netherlands; Pyrimidines; Reproducibility of Results; Survival Analysis; Triazoles; Voriconazole | 2007 |
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole | 2007 |
[A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Male; Orbital Diseases; Pyrimidines; Triazoles; Voriconazole | 2007 |
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2007 |
Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
The use of voriconazole in the treatment of Aspergillus fumigatus keratitis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Keratitis; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].
Topics: Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cytochrome P-450 Enzyme System; Humans; Lung Diseases, Fungal; Male; Pituitary ACTH Hypersecretion; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation; Drug Resistance, Fungal; Fluconazole; Humans; Injections, Intravenous; Molecular Structure; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Images in HIV/AIDS. Invasive aspergillosis presenting as a neck mass in a person with HIV/AIDS.
Topics: Adult; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; HIV Infections; Humans; Male; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Lack of cross-hepatotoxicity between voriconazole and posaconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chemical and Drug Induced Liver Injury; Humans; Pyrimidines; Triazoles; Voriconazole | 2007 |
Plasma concentrations of voriconazole in falcons.
Topics: Animals; Antifungal Agents; Aspergillosis; Biological Availability; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Necrosis; Pyrimidines; Radiography; Triazoles; Voriconazole | 2007 |
Comparison of 2 studies of treatment of invasive aspergillosis.
Topics: Amphotericin B; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Aspergillus fumigatus keratitis following laser in situ keratomileusis.
Topics: Adult; Amputation, Surgical; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Corneal Ulcer; Debridement; Eye Infections, Fungal; Female; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Pyrimidines; Surgical Flaps; Triazoles; Voriconazole | 2007 |
Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Female; Humans; Immunocompromised Host; Leukemia; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Antilymphocyte Serum; Aspergillosis; Aspergillus fumigatus; Discitis; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Case of invasive sino-orbital aspergillosis developing orbital apex syndrome].
Topics: Aged; Antifungal Agents; Aspergillosis; Cavernous Sinus; Cranial Nerve Diseases; Female; Headache; Humans; Orbit; Orbital Diseases; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Diseases; Pyrimidines; Syndrome; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole | 2007 |
Invasive tracheal aspergillosis treated successfully with voriconazole: clinical report and review of the literature.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Fatal Outcome; Female; Humans; Laryngoscopy; Leukemia, Myeloid, Acute; Opportunistic Infections; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2007 |
Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chemotherapy, Adjuvant; Drug Evaluation; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Lung Diseases, Fungal; Models, Economic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2007 |
A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Liver Transplantation; Living Donors; Lung Diseases, Fungal; Middle Aged; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Aspergillosis; Child; Cohort Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2008 |
[Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Topics: Acute Kidney Injury; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Critical Illness; Fatal Outcome; Half-Life; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole | 2008 |
Use of voriconazole in fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aspergillosis; Chloramphenicol; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Humans; Middle Aged; Pyrimidines; Staphylococcal Infections; Triazoles; Visual Acuity; Voriconazole | 2008 |
Voriconazole plasma monitoring.
Topics: Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Drug Monitoring; Humans; Leukemia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2008 |
Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
Topics: Aged; Antifungal Agents; Aspergillosis; Carcinoma, Squamous Cell; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Postoperative Complications; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2008 |
Invasive Aspergillus terreus sinusitis with orbitocranial extension: case report.
Topics: Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2008 |
Aspergillus "fungus ball" of the bladder after hematopoietic transplantation in a pediatric patient: successful treatment with intravesical voriconazole and surgery.
Topics: Administration, Intravesical; Adolescent; Anemia, Sickle Cell; Antifungal Agents; Aspergillosis; Cystitis; Hematopoietic Stem Cell Transplantation; Humans; Male; Pyrimidines; Triazoles; Urinary Bladder Diseases; Voriconazole | 2008 |
Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus.
Topics: Adolescent; Adult; Aspergillosis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Lung Transplantation; Male; Middle Aged; Neuromuscular Diseases; Pain; Postoperative Complications; Pyrimidines; Retrospective Studies; Risk Assessment; Severity of Illness Index; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Clinical case of the month. Pulmonary aspergillosis: chimic necrotizing aspergillosis].
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Chronic Disease; Glucocorticoids; Humans; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Necrosis; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Sputum; Triazoles; Voriconazole | 2007 |
The use of voriconazole for the treatment of aspergillosis in falcons (Falco species).
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Male; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole in newborns.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus].
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bone Diseases, Infectious; Caspofungin; Echinocandins; Humans; Lipopeptides; Lung; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Cross Infection; Disease Outbreaks; Environmental Exposure; Hematology; Hospital Design and Construction; Hospital Units; Humans; Infection Control; Pyrimidines; Triazoles; Voriconazole | 2008 |
Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intralesional; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Biomarkers; Clinical Trials as Topic; Galactose; Humans; Immunoglobulin E; Lung Diseases, Fungal; Lung Diseases, Interstitial; Mannans; Practice Guidelines as Topic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2007 |
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thyroid Diseases; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Female; Kidney Diseases; Liver Diseases; Lung Diseases, Fungal; Pyrimidines; Rabbits; Triazoles; Voriconazole | 1996 |
Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Dose-Response Relationship, Drug; Endocarditis; Guinea Pigs; Itraconazole; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1997 |
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Leukemia; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 1997 |
Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 1998 |
Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Child, Preschool; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 1998 |
Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.
Topics: Aged; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Drug Resistance, Microbial; Female; Galactose; Humans; Mannans; Meningitis, Fungal; Mycology; Polymerase Chain Reaction; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 1999 |
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Voriconazole. UK 109496.
Topics: Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Drugs, Investigational; Fungi; Guinea Pigs; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2000 |
Voriconazole: a new triazole antifungal.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Controlled Clinical Trials as Topic; Drug Interactions; Drug Resistance, Microbial; Humans; Pyrimidines; Retrospective Studies; Tissue Distribution; Triazoles; Voriconazole | 2000 |
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fluocinolone Acetonide; Glucocorticoids; Guinea Pigs; Immunocompromised Host; Immunosuppressive Agents; Male; Organ Culture Techniques; Pyrimidines; Triazoles; Voriconazole | 2000 |
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Diagnostic Errors; DNA, Fungal; Galactose; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung Abscess; Lung Diseases, Fungal; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2000 |
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole | 2000 |
[Invasive aspergillosis on a surgical intensive care unit].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2000 |
Clinical activity of the new triazole drug voriconazole (UK 109, 496) against disseminated hepatosplenic aspergillosis in a patient with relapsed leukemia.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Humans; Immunosuppression Therapy; Leukemia, Myeloid; Liver Diseases; Male; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2001 |
Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Drug Therapy, Combination; Humans; Male; Maxillary Sinus; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2000 |
Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Cheilitis; Erythema; Female; Humans; Lung Diseases, Fungal; Lupus Erythematosus, Discoid; Male; Middle Aged; Pyrimidines; Retinoids; Sinusitis; Triazoles; Voriconazole | 2001 |
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2001 |
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole | 2002 |
Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |